	Live Single immune cells(FSC-H_FSC-W)|2016-09-19_PANEL_2_DHS_Group_one_F1636912_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-19_PANEL_2_DHS_Group_two_Ctl-C_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-20_PANEL_2_DHS_Group_one_F1637258_012|manual
	CD14-|2016-09-19_PANEL_2_DHS_Group_one_F1636932_007|manual
	DC NK (CD20- CD14-)|2016-09-16_PANEL_2_ZF_Group_one_F1631102_010|manual
	NK CD56LO|2016-09-19_PANEL_2_DHS_Group_one_F1636902_014|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-13_PANEL_2_DHS_Group_two_Ctl-D_032|manual
	CD14-|2016-09-20_PANEL_2_DHS_Group_one_F1636931_005|manual
	Live immune cells (CD45+ PE-)|2016-09-20_PANEL_2_DHS_Group_one_F1637205_011|manual
	Live immune cells (CD45+ PE-)|2016-09-14_PANEL_2_ZF_Group_one_F1636662_004|manual
	DC NK (CD20- CD14-)|2016-09-16_PANEL_2_ZF_Group_two_F1636670_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-09-19_PANEL_2_DHS_Group_two_F1637211_032|manual
	CD14-|2016-09-13_PANEL_2_DHS_Group_one_F1636633_004|manual
	Classical monocytes (CD16- CD14+)|2016-09-14_PANEL_2_ZF_Group_one_F1636808_002|manual
	NK CD56LO|2016-09-15_PANEL_2_ZF_Group_two_F1636622_032|manual
	CD14-|2016-09-15_PANEL_2_ZF_Group_two_F1636622_032|manual
	Classical monocytes (CD16- CD14+)|2016-09-15_PANEL_2_ZF_Group_two_F1636622_032|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-09-13_PANEL_2_DHS_Group_one_F1636596_001|manual
	NK CD56LO|2016-09-19_PANEL_2_DHS_Group_one_F1636867_016|manual
	Classical monocytes (CD16- CD14+)|2016-09-19_PANEL_2_DHS_Group_one_F1636867_016|manual
	Classical monocytes (CD16- CD14+)|2016-09-15_PANEL_2_ZF_Group_two_F1636623_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-20_PANEL_2_DHS_Group_one_F1636680_004|manual
	DC NK (CD20- CD14-)|2016-09-16_PANEL_2_ZF_Group_one_F1636569_003|manual
	DC NK (CD20- CD14-)|2016-09-16_PANEL_2_ZF_Group_two_F1636565_028|manual
	DC (HLA-DR+)|2016-09-16_PANEL_2_ZF_Group_two_F1636581_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-16_PANEL_2_ZF_Group_two_F1636890_031|manual
	DC NK (CD20- CD14-)|2016-09-16_PANEL_2_ZF_Group_two_F1636614_026|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-09-09_PANEL_2_ZF_Group_two_F1636641_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-15_PANEL_2_ZF_Group_one_F1636606_004|manual
	DC NK (CD20- CD14-)|2016-09-16_PANEL_2_ZF_Group_one_F1636563_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-19_PANEL_2_DHS_Group_one_F1632401_013|manual
	NK CD56LO|2016-09-09_PANEL_2_ZF_Group_one_F1636908_003|manual
	DC NK (CD20- CD14-)|2016-09-16_PANEL_2_ZF_Group_one_F1636905_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-15_PANEL_2_ZF_Group_two_F1636643_027|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-09-15_PANEL_2_ZF_Group_one_F1636625_001|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-09-27_PANEL_2_DHS_Group_one_F1637207_001|manual
	NK CD56LO|2016-10-10_PANEL_2_DHS_Group_two_F1636448_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-04_PANEL_2_DHS_Group_one_F1636444_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-11_PANEL_2_DHS_Group_one_F1636447_003|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-09-26_PANEL_2_DHS_Group_one_F1637245_002|manual
	CD14-|2016-09-26_PANEL_2_DHS_Group_one_F1637195_001|manual
	CD14-|2016-10-05_PANEL_2_ZF_Group_one_Ctl-A_001|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-09-27_PANEL_2_DHS_Group_one_F1637238_010|manual
	DC (HLA-DR+)|2016-10-04_PANEL_2_DHS_Group_two_F1637242_031|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-10-10_PANEL_2_DHS_Group_two_F1636691_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-10-03_PANEL_2_DHS_Group_one_F1637192_013|manual
	DC (HLA-DR+)|2016-10-10_PANEL_2_DHS_Group_one_F1637247_006|manual
	NK CD56LO|2016-10-25_PANEL_2_ZF_Group_one_F1636986_008|manual
	NK CD56LO|2016-10-17_PANEL_2_DHS_Group_two_F1636917_040|manual
	NK CD56LO|2016-10-24_PANEL_2_DHS_Group_one_F1636451_002|manual
	NK CD56LO|2016-10-24_PANEL_2_DHS_Group_two_F1637333_028|manual
	DC (HLA-DR+)|2016-10-27_PANEL_2_DHS_Group_one_F1637016_005|manual
	NK CD56LO|2016-10-17_PANEL_2_DHS_Group_one_F1636417_015|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-10-18_PANEL_2_DHS_Group_two_F1637166_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-24_PANEL_2_DHS_Group_one_F1636712_014|manual
	NK CD56LO|2016-10-18_PANEL_2_DHS_Group_one_F1636431_014|manual
	NK CD56LO|2016-10-24_PANEL_2_DHS_Group_one_F1637317_005|manual
	DC (HLA-DR+)|2016-10-20_PANEL_2_ZF_Group_one_F1636486_003|manual
	Classical monocytes (CD16- CD14+)|2016-10-25_PANEL_2_ZF_Group_one_F1637283_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-10-20_PANEL_2_ZF_Group_one_F1637190_001|manual
	Classical monocytes (CD16- CD14+)|2016-10-27_PANEL_2_DHS_Group_one_F1637300_002|manual
	DC (HLA-DR+)|2016-10-25_PANEL_2_ZF_Group_one_Ctl-D_011|manual
	Classical monocytes (CD16- CD14+)|2016-10-25_PANEL_2_ZF_Group_one_F1636987_003|manual
	CD45+|2016-10-17_PANEL_2_DHS_Group_one_F1637218_004|manual
	CD14-|2016-10-17_PANEL_2_DHS_Group_one_F1637218_004|manual
	Classical monocytes (CD16- CD14+)|2016-10-24_PANEL_2_DHS_Group_two_F1637215_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-10-25_PANEL_2_ZF_Group_one_F1637327_002|manual
	Classical monocytes (CD16- CD14+)|2016-10-17_PANEL_2_DHS_Group_two_F1637188_037|manual
	DC (HLA-DR+)|2016-10-18_PANEL_2_DHS_Group_one_F1636462_007|manual
	DC (HLA-DR+)|2016-10-27_PANEL_2_DHS_Group_one_F1637029_008|manual
	Classical monocytes (CD16- CD14+)|2016-10-17_PANEL_2_DHS_Group_two_F1636882_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-11_PANEL_2_DHS_Group_one_F1637282_010|manual
	DC (HLA-DR+)|2016-10-17_PANEL_2_DHS_Group_one_F1637181_010|manual
	NK CD56LO|2016-10-18_PANEL_2_DHS_Group_one_F1636674_001|manual
	NK CD56LO|2016-10-18_PANEL_2_DHS_Group_two_F1636423_031|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-10-27_PANEL_2_DHS_Group_one_F1637286_010|manual
	NK CD56LO|2016-10-31_PANEL_2_DHS_Group_one_F1637305_013|Manual
	NK CD56LO|2016-10-28_PANEL_2_ZF_Group_one_F1637168_011|Manual
	NK CD56LO|2016-11_02_PANEL_2_ZF_Group_one_F1637270_002|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11_02_PANEL_2_ZF_Group_one_Ctl-A_015|Manual
	NK CD56LO|2016-10-31_PANEL_2_DHS_Group_one_F1637265_009|Manual
	Classical monocytes (CD16- CD14+)|2016-10-27_PANEL_2_DHS_Group_two_F1637328_035|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11_02_PANEL_2_ZF_Group_one_F1637026_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-31_PANEL_2_DHS_Group_two_Ctl-D_039|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-31_PANEL_2_DHS_Group_one_F1636953_011|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-27_PANEL_2_DHS_Group_one_F1637322_003|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-28_PANEL_2_ZF_Group_one_F1637004_013|Manual
	NK CD56LO|2016-10-28_PANEL_2_ZF_Group_one_F1637004_013|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-31_PANEL_2_DHS_Group_one_F1637012_010|Manual
	DC NK (CD20- CD14-)|2016-10-31_PANEL_2_DHS_Group_one_F1637012_010|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-10-31_PANEL_2_DHS_Group_one_F1637012_010|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11_02_PANEL_2_ZF_Group_one_F1637977_013|Manual
	CD14-|2016-11-01_PANEL_2_DHS_Group_one_F1636981_013|Manual
	Classical monocytes (CD16- CD14+)|2016-11-01_PANEL_2_DHS_Group_one_F1636981_013|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-01_PANEL_2_DHS_Group_one_F1636981_013|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-11-01_PANEL_2_DHS_Group_one_F1636981_013|Manual
	DC NK (CD20- CD14-)|2016-10-31_PANEL_2_DHS_Group_one_F1636426_007|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-10-31_PANEL_2_DHS_Group_one_F1636426_007|Manual
	NK CD56LO|2016-10-28_PANEL_2_ZF_Group_one_F1637179_007|Manual
	Classical monocytes (CD16- CD14+)|2016-10-31_PANEL_2_DHS_Group_one_F1636968_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-31_PANEL_2_DHS_Group_one_F1636966_004|Manual
	Classical monocytes (CD16- CD14+)|2016-10-31_PANEL_2_DHS_Group_two_F1636642_028|Manual
	NK CD56LO|2016-10-28_PANEL_2_ZF_Group_one_F1637285_001|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-10-31_PANEL_2_DHS_Group_two_F1636449_033|Manual
	NK CD56LO|2016-10-28_PANEL_2_ZF_Group_one_F1636432_015|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-04_PANEL_2_ZF_Group_one_Ctl-D_ZF_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-07_PANEL_2_ZF_Group_one_Ctl-D_015|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-07_PANEL_2_ZF_Group_one_F1637275_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652339_007|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652327_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-10_PANEL_2_ZF_Group_one_F1637031_002|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652357_004|manual
	DC (HLA-DR+)|2016-11-07_PANEL_2_ZF_Group_one_F1636993_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-03_PANEL_2_ZF_Group_one_Ctl-D_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652319_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-04_PANEL_2_ZF_Group_one_Ctl-D_HB_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-04_PANEL_2_HB-ctl_P2_Ctl-D-ZF_008|manual
	NK CD56LO|2016-11-11_PANEL_2_ZF_Group_one_F1652455_006|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652373_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-10_PANEL_2_ZF_Group_two_F1635599_025|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652321_003|manual
	Classical monocytes (CD16- CD14+)|2016-11-14_PANEL_2_DHS_Group_one_F1652908_012|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652368_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-07_PANEL_2_ZF_Group_one_F1637001_002|manual
	DC NK (CD20- CD14-)|2016-11-14_PANEL_2_DHS_Group_two_F1652326_032|manual
	DC NK (CD20- CD14-)|2016-11-14_PANEL_2_DHS_Group_two_F1652380_035|manual
	Classical monocytes (CD16- CD14+)|2016-11-11_PANEL_2_ZF_Group_one_F1652360_007|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-11_PANEL_2_ZF_Group_one_F1652360_007|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15-PANEL_2_HB_HRS_F1652334_005|manual
	Classical monocytes (CD16- CD14+)|2016-11-14_PANEL_2_DHS_Group_one_F1635603_007|manual
	NK CD56LO|2016-11-08_PANEL_2__ZF_Group_one_F1637295_002|manual
	CD45+|2016-11-09_PANEL_2_HB_P2_HRS034-D72_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-10_PANEL_2_ZF_Group_two_F1637266_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-10_PANEL_2_ZF_Group_one_F1632362_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-01_PANEL_2_DHS_Group_two_F1638205_038|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-11-01_PANEL_2_DHS_Group_two_F1638205_038|manual
	DC (HLA-DR+)|2016-11-08_PANEL_2__ZF_Group_one_F1637010_010|manual
	NK CD56LO|2016-11-07_PANEL_2_ZF_Group_one_F1637269_011|manual
	Classical monocytes (CD16- CD14+)|2016-11-14_PANEL_2_DHS_Group_one_F1635602_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-10_PANEL_2_ZF_Group_two_Ctl-B_027|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-15_PANEL_2_DHS_Group_two_F1637268_027|manual
	NK CD56LO|2016-11-22_PANEL_2_DHS_Group_two_F1636682_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-28_PANEL_2_DHS_Group_one_F1635854_001|manual
	NK CD56LO|2016-11-28_PANEL_2_DHS_Group_one_F1635854_001|manual
	DC (HLA-DR+)|2016-11-17_PANEL_2_ZF_Group_two_F1637028_024|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-11-17_PANEL_2_ZF_Group_two_F1637028_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-24_PANEL_2_HB_HRS_P2-GROUP2_F1635895_006|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-11-17_PANEL_2_ZF_Group_two_F1652335_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-17_PANEL_2_ZF_Group_one_F1652900_007|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-11-23_PANEL_2_HB_HRS-P2-GROUP2_F1631375_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-28_PANEL_2_DHS_Group_one_F1635853_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-24_PANEL_2_HB_HRS_P2-GROUP2_F1635637_008|manual
	NK CD56LO|2016-11-17_PANEL_2_ZF_Group_two_F1652916_023|manual
	NK CD56LO|2016-11-22_PANEL_2_DHS_Group_one_F1652902_003|manual
	CD14-|2016-11-22_PANEL_2_DHS_Group_one_F1652902_003|manual
	NK CD56LO|2016-11-22_PANEL_2_DHS_Group_one_F1637278_006|manual
	CD14-|2016-11-22_PANEL_2_DHS_Group_one_F1637278_006|manual
	Classical monocytes (CD16- CD14+)|2016-11-22_PANEL_2_DHS_Group_one_F1637278_006|manual
	DC (HLA-DR+)|2016-11-17_PANEL_2_ZF_Group_one_F1637226_002|manual
	Classical monocytes (CD16- CD14+)|2016-11-17_PANEL_2_ZF_Group_one_F1637226_002|manual
	NK CD56LO|2016-11-17_PANEL_2_ZF_Group_one_F1652325_001|manual
	NK CD56LO|2016-11-23_PANEL_2_ZF_Group_two_F1652468_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-28_PANEL_2_DHS_Group_one_F1635615_009|manual
	NK CD56LO|2016-11-23_PANEL_2_HB_HRS-P2-GROUP2_F1635891_028|manual
	CD14-|2016-11-24_PANEL_2_HB_HRS_P2-GROUP2_F1635849_001|manual
	DC (HLA-DR+)|2016-11-28_PANEL_2_DHS_Group_one_F1635906_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-17_PANEL_2_ZF_Group_one_F1652905_004|manual
	NK CD56LO|2016-11-17_PANEL_2_ZF_Group_one_F1652905_004|manual
	DC (HLA-DR+)|2016-11-17_PANEL_2_ZF_Group_one_F1652905_004|manual
	CD14-|2016-11-17_PANEL_2_ZF_Group_one_F1652905_004|manual
	Classical monocytes (CD16- CD14+)|2016-11-17_PANEL_2_ZF_Group_one_F1652905_004|manual
	CD45+|2016-11-22_PANEL_2_DHS_Group_two_Ctl-A_039|manual
	DC (HLA-DR+)|2016-11-23_PANEL_2_ZF_Group_one_F1635626_009|manual
	Classical monocytes (CD16- CD14+)|2016-11-30_PANEL_2_DHS_ZF_Group_two_ZF_F1652432_035|manual
	Classical monocytes (CD16- CD14+)|2016-11-30_PANEL_2_DHS_ZF_Group_one_DHS_F1635889_001|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-30_PANEL_2_DHS_ZF_Group_one_DHS_F1635889_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-30_PANEL_2_DHS_ZF_Group_one_DHS_F1637236_004|manual
	NK CD56LO|2016-11-30_PANEL_2_DHS_ZF_Group_one_DHS_F1635614_002|manual
	Classical monocytes (CD16- CD14+)|2016-12-02_PANEL_2_ZF_Group_one_F1635658_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-11-29_PANEL_2_ZF_Group_one_F1637232_009|manual
	NK CD56LO|2016-11-29_PANEL_2_ZF_Group_one_F1635904_001|manual
	NK CD56LO|2016-12-02_PANEL_2_HB_group_one_F1652310_003|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-02_PANEL_2_HB_group_one_F1652310_003|manual
	NK CD56LO|2016-11-29_PANEL_2_ZF_Group_one_F1636939_005|manual
	NK CD56LO|2016-11-30_PANEL_2_DHS_ZF_Group_one_DHS_F1652877_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12_19_PANEL_2_ZF_Group_two_F1637395_020|manual
	NK CD56LO|2016-11-29_PANEL_2_ZF_Group_one_F1636578_007|manual
	NK CD56LO|2016-11-29_PANEL_2_ZF_Group_one_F1635876_008|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-11-30_PANEL_2_DHS_ZF_Group_one_DHS_F1652723_013|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-11-30_PANEL_2_DHS_ZF_Group_one_DHS_F1652723_013|manual
	Classical monocytes (CD16- CD14+)|2016-12-02_PANEL_2_ZF_Group_one_F1630984_008|manual
	DC (HLA-DR+)|2016-11-28_PANEL_2_DHS_Group_two_F1652440_037|manual
	Classical monocytes (CD16- CD14+)|2016-12-02_PANEL_2_ZF_Group_one_F1630941_003|manual
	NK CD56LO|2016-11-28_PANEL_2_DHS_Group_two_F1636571_027|manual
	NK CD56LO|2016-12-08_PANEL_2_ZF_Group_one_F1635851_008|Manual
	NK CD56LO|2016-12-09_PANEL_2_HB_group_two_F1636396_025|Manual
	NK CD56LO|2016-12-03_PANEL_2_ZF_Group_two_F1652274_021|Manual
	NK CD56LO|2016-12-08_PANEL_2_ZF_Group_one_F1652445_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-05_PANEL_2_DHS_Group_two_F1652250_029|Manual
	NK CD56LO|2016-12-03_PANEL_2_ZF_Group_two_F1652385_026|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-08_PANEL_2_ZF_Group_two_F1636140_022|Manual
	NK CD56LO|2016-12-09_PANEL_2_HB_group_one_F1652236_002|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-03_PANEL_2_ZF_Group_one_F1652296_007|Manual
	NK CD56LO|2016-12-03_PANEL_2_ZF_Group_one_F1652296_007|Manual
	NK CD56LO|2016-12-09_PANEL_2_HB_group_one_F1636065_004|Manual
	DC NK (CD20- CD14-)|2016-12-09_PANEL_2_HB_group_one_F1636065_004|Manual
	NK CD56LO|2016-12-03_PANEL_2_ZF_Group_one_F1635860_003|Manual
	NK CD56LO|2016-12-05_PANEL_2_DHS_Group_one_F1652243_005|Manual
	Classical monocytes (CD16- CD14+)|2016-12-05_PANEL_2_DHS_Group_one_F1652243_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-05_PANEL_2_DHS_Group_two_F1652254_040|Manual
	NK CD56LO|2016-12-03_PANEL_2_ZF_Group_one_F1652289_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-05_PANEL_2_DHS_Group_one_F1652299_006|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-03_PANEL_2_ZF_Group_two_Ctl-D_028|Manual
	Classical monocytes (CD16- CD14+)|2016-12-03_PANEL_2_ZF_Group_two_Ctl-D_028|Manual
	NK CD56LO|2016-12-09_PANEL_2_HB_group_one_F1636080_001|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-03_PANEL_2_ZF_Group_two_F1652239_025|Manual
	Classical monocytes (CD16- CD14+)|2016-12-03_PANEL_2_ZF_Group_two_F1636963_022|Manual
	NK CD56LO|2016-12-09_PANEL_2_HB_group_two_F1652271_024|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-03_PANEL_2_ZF_Group_one_F1652279_004|Manual
	NK CD56LO|2016-12-03_PANEL_2_ZF_Group_one_F1652279_004|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-09_PANEL_2_ZF_Group_two_Ctl-D_028|Manual
	NK CD56LO|2016-12-09_PANEL_2_HB_group_one_F1636406_010|Manual
	NK CD56LO|2016-12-03_PANEL_2_ZF_Group_one_F1652307_002|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-08_PANEL_2_ZF_Group_one_F1636306_007|Manual
	NK CD56LO|2016-12-09_PANEL_2_ZF_Group_one_F1636087_009|Manual
	Classical monocytes (CD16- CD14+)|2016-12-09_PANEL_2_ZF_Group_one_F1636087_009|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-08_PANEL_2_ZF_Group_one_F1652263_002|Manual
	NK CD56LO|2016-12-12_PANEL_2_DHS_Group_two_F1636393_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-14_PANEL_2_ZF_Group_two_F1636154_027|manual
	NK CD56LO|2016-12-13_PANEL_2_DHS_Group_one_F1636122_011|manual
	NK CD56LO|2016-12-12_PANEL_2_DHS_Group_one_F1636399_011|manual
	DC (HLA-DR+)|2016-12-14_PANEL_2_ZF_Group_two_F1636049_023|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-12_PANEL_2_DHS_Group_two_F1636089_034|manual
	Classical monocytes (CD16- CD14+)|2016-12-15_PANEL_2_HB_group_two_F1635983_029|manual
	CD14-|2016-12-12_PANEL_2_DHS_Group_two_F1636056_036|manual
	DC (HLA-DR+)|2016-12-15_PANEL_2_ZF_Group_one_F1635982_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-15_PANEL_2_HB_group_one_F1637257_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-14_PANEL_2_ZF_Group_one_F1636388_003|manual
	DC (HLA-DR+)|2016-12-15_PANEL_2_HB_group_two_F1649321_031|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-14_PANEL_2_TORI_P2_P2-FMO_CD19_003|manual
	CD14-|2016-12-15_PANEL_2_HB_group_one_F1636319_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-13_PANEL_2_DHS_Group_one_F1637015_002|manual
	NK CD56LO|2016-12-13_PANEL_2_DHS_Group_two_F1636048_030|manual
	Classical monocytes (CD16- CD14+)|2016-12-15_PANEL_2_HB_group_one_F1636145_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-16_PANEL_2_HB_group_one_F1636234_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-20_PANEL_2_ZF_Group_one_F1635953_002|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-19_PANEL_2_ZF_Group_two_F1637137_024|manual
	NK CD56LO|2016-12-16_PANEL_2_HB_group_two_F1637376_030|manual
	NK CD56LO|2016-12-16_PANEL_2_HB_group_two_F1637382_031|manual
	Classical monocytes (CD16- CD14+)|2016-12-16_PANEL_2_HB_group_two_F1637382_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-19_PANEL_2_ZF_Group_two_F1636331_022|manual
	Classical monocytes (CD16- CD14+)|2016-12-20_PANEL_2_HB_group_two_F1636195_023|manual
	NK CD56LO|2016-12-15_PANEL_2_ZF_Group_two_F1636040_028|manual
	NK CD56LO|2016-12-16_PANEL_2_HB_group_two_F1637384_029|manual
	CD45+|2016-12-16_PANEL_2_HB_group_one_F1636295_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-20_PANEL_2_ZF_Group_one_F1636309_003|manual
	NK CD56LO|2016-12-20_PANEL_2_ZF_Group_one_F1636215_001|manual
	NK CD56LO|2016-12-16_PANEL_2_HB_group_one_F1636289_004|manual
	Classical monocytes (CD16- CD14+)|2016-12-20_PANEL_2_HB_group_two_F1636202_026|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-20_PANEL_2_HB_group_two_F1636202_026|manual
	NK CD56LO|2016-12-15_PANEL_2_ZF_Group_one_F1652332_001|manual
	CD45+|2016-12-16_PANEL_2_HB_group_two_F1636354_023|manual
	Live immune cells (CD45+ PE-)|2016-12-20_PANEL_2_HB_group_two_F1636216_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-20_PANEL_2_ZF_Group_one_F1636226_007|manual
	NK CD56LO|2016-12-20_PANEL_2_HB_group_one_F1636050_007|manual
	NK CD56LO|2016-05-17_PANEL_2_DHS_panel_2_F1632187_008|manual
	Classical monocytes (CD16- CD14+)|2016-05-17_PANEL_2_DHS_panel_2_F1632187_008|manual
	NK CD56LO|2016-05-05_PANEL_2_HB_panel_two_F1631931_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-05-12_PANEL_2_HB_panel_2_F1631932_016|manual
	NK CD56LO|2016-05-12_PANEL_2_HB_panel_2_F1631932_016|manual
	Classical monocytes (CD16- CD14+)|2016-05-12_PANEL_2_HB_panel_2_F1631932_016|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-05-12_PANEL_2_HB_panel_2_F1631932_016|manual
	NK CD56LO|2016-05-17_PANEL_2_DHS_panel_2_F1632234_005|manual
	NK CD56LO|2016-05-05_PANEL_2_HB_panel_two_F1631959_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-05-12_PANEL_2_HB_panel_2_F1631928_015|manual
	NK CD56LO|2016-05-12_PANEL_2_HB_panel_2_F1631928_015|manual
	Classical monocytes (CD16- CD14+)|2016-05-12_PANEL_2_HB_panel_2_F1631928_015|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-05-12_PANEL_2_HB_panel_2_F1631928_015|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-05-12_PANEL_2_HB_panel_2_F1631928_015|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-01-08_PANEL_2_HB_Group_one_Ctl-A_002|manual
	NK CD56LO|2016-05-05_PANEL_2_HB_panel_two_F1631960_004|manual
	CD14-|2016-05-05_PANEL_2_HB_panel_two_F1631960_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-05-12_PANEL_2_HB_panel_2_Ctl-C_014|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-05-17_PANEL_2_DHS_panel_2_F1632261_014|manual
	NK CD56LO|2016-05-16_PANEL_2_DHS_panel_2_F1632183_013|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-05-17_PANEL_2_DHS_panel_2_Ctl-D_016|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-05-10_PANEL_2_HB_panel_2_Ctl-D_011|manual
	NK CD56LO|2016-05-16_PANEL_2_DHS_panel_2_F1632231_011|manual
	DC (HLA-DR+)|2016-05-17_PANEL_2_DHS_panel_2_F1631917_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-01-08_PANEL_2_HB_Group_one_Ctl-D_004|manual
	DC NK (CD20- CD14-)|2016-01-08_PANEL_2_HB_Group_one_Ctl-D_004|manual
	CD14-|2016-01-08_PANEL_2_HB_Group_one_Ctl-D_004|manual
	Classical monocytes (CD16- CD14+)|2016-01-08_PANEL_2_HB_Group_one_Ctl-D_004|manual
	NK CD56LO|2016-05-18_PANEL_2_ZF_panel_2_Ctl-A_016|manual
	Classical monocytes (CD16- CD14+)|2016-05-18_PANEL_2_ZF_panel_2_Ctl-A_016|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-05-10_PANEL_2_HB_panel_2_F1632186_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-01-08_PANEL_2_HB_Group_one_Ctl-C_003|manual
	NK CD56LO|2016-05-09_PANEL_2_DHS_panel_2_F1631951_003|manual
	DC (HLA-DR+)|2016-05-09_PANEL_2_DHS_panel_2_F1631951_003|manual
	Classical monocytes (CD16- CD14+)|2016-05-09_PANEL_2_DHS_panel_2_F1631951_003|manual
	Classical monocytes (CD16- CD14+)|2016-05-16_PANEL_2_DHS_panel_2_F1632230_012|manual
	Classical monocytes (CD16- CD14+)|2016-05-17_PANEL_2_DHS_panel_2_F1632245_015|manual
	Classical monocytes (CD16- CD14+)|2016-05-17_PANEL_2_DHS_panel_2_F1632242_013|manual
	NK CD56LO|2016-05-11_PANEL_2_ZF_panel_2_F1632229_002|manual
	Classical monocytes (CD16- CD14+)|2016-05-17_PANEL_2_DHS_panel_2_F1631923_007|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-05-12_PANEL_2_HB_panel_2_F1632260_008|manual
	CD14-|2016-05-12_PANEL_2_HB_panel_2_F1632220_012|manual
	Classical monocytes (CD16- CD14+)|2016-05-12_PANEL_2_HB_panel_2_F1632220_012|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-05-16_PANEL_2_DHS_panel_2_F1632174_016|manual
	NK CD56LO|2016-05-11_PANEL_2_ZF_panel_2_F1631925_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-21_PANEL_2_ZF_Group_one_F1635631_005|manual
	Classical monocytes (CD16- CD14+)|2016-12-21_PANEL_2_ZF_Group_one_F1635631_005|manual
	CD14-|2016-12-22_PANEL_2_HB_group_one_F1636301_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_two_F1637105_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_two_F1637410_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-20_PANEL_2_ZF_Group_two_F1652375_027|manual
	Live immune cells (CD45+ PE-)|2016-12-21_PANEL_2_ZF_Group_one_F1636223_013|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-22_PANEL_2_ZF_Group_one_F1636352_016|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-21_PANEL_2_ZF_Group_one_F1636042_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-20_PANEL_2_ZF_Group_two_F1637388_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_two_F1638627_037|manual
	Live immune cells (CD45+ PE-)|2016-12-27_PANEL_2_ZF_Group_two_F1638627_037|manual
	Live immune cells (CD45+ PE-)|2016-12-27_PANEL_2_ZF_Group_two_F1652649_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-22_PANEL_2_ZF_Group_one_F1637361_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_one_F1652256_014|manual
	CD45+|2016-12-22_PANEL_2_HB_group_one_F1635972_005|manual
	DC NK (CD20- CD14-)|2016-12-22_PANEL_2_HB_group_one_F1635972_005|manual
	Live immune cells (CD45+ PE-)|2016-12-22_PANEL_2_HB_group_one_F1635972_005|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-12-22_PANEL_2_HB_group_one_F1635972_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-22_PANEL_2_ZF_Group_one_F1636336_006|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-12-22_PANEL_2_HB_group_one_F1636512_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-21_PANEL_2_ZF_Group_one_F1636291_016|manual
	DC (HLA-DR+)|2016-12-21_PANEL_2_ZF_Group_one_F1636291_016|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_two_F1637144_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-22_PANEL_2_HB_group_one_F1652372_002|manual
	Live immune cells (CD45+ PE-)|2016-12-22_PANEL_2_HB_group_one_F1652372_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-21_PANEL_2_ZF_Group_one_F1635958_015|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_one_F1637049_005|manual
	Classical monocytes (CD16- CD14+)|2016-12-27_PANEL_2_ZF_Group_one_F1635912_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-22_PANEL_2_ZF_Group_one_F1637100_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_one_F1637090_009|manual
	Classical monocytes (CD16- CD14+)|2016-12-27_PANEL_2_ZF_Group_one_F1637090_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-22_PANEL_2_HB_group_one_F1636059_007|manual
	CD14-|2016-12-22_PANEL_2_HB_group_one_F1636059_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_one_F1637059_006|manual
	Classical monocytes (CD16- CD14+)|2016-12-27_PANEL_2_HB_group_one_F1636339_010|manual
	DC (HLA-DR+)|2016-12-22_PANEL_2_HB_group_two_F1637185_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-21_PANEL_2_ZF_Group_one_F1636200_002|manual
	Live immune cells (CD45+ PE-)|2016-12-21_PANEL_2_ZF_Group_one_F1636200_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-22_PANEL_2_HB_group_one_F1636969_001|manual
	Live immune cells (CD45+ PE-)|2016-12-22_PANEL_2_HB_group_one_F1636969_001|manual
	Classical monocytes (CD16- CD14+)|2016-12-27_PANEL_2_HB_group_two_F1636362_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_one_F1635899_001|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-12-27_PANEL_2_ZF_Group_one_F1632279_010|manual
	DC (HLA-DR+)|2016-12-22_PANEL_2_ZF_Group_one_F1636318_008|manual
	CD45+|2016-12-21_PANEL_2_ZF_Group_one_F1636361_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-27_PANEL_2_ZF_Group_one_F1637380_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-21_PANEL_2_ZF_Group_one_F1635945_014|manual
	CD14-|2016-12-22_PANEL_2_HB_group_one_F1635968_009|manual
	Live immune cells (CD45+ PE-)|2016-12-22_PANEL_2_HB_group_one_F1635968_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-21_PANEL_2_ZF_Group_one_F1631240_003|manual
	CD14-|2016-12-21_PANEL_2_ZF_Group_one_F1631240_003|manual
	Live immune cells (CD45+ PE-)|2016-12-21_PANEL_2_ZF_Group_one_F1631240_003|manual
	Classical monocytes (CD16- CD14+)|2016-12-21_PANEL_2_ZF_Group_one_F1631240_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-29_PANEL_2_ZF_Group_one_F1637387_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-30_PANEL_2_HB_group_two_F1635921_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-29_PANEL_2_HB_group_one_F1637353_005|manual
	NK CD56LO|2016-12-29_PANEL_2_HB_group_one_F1637353_005|good
	Live Single immune cells(FSC-H_FSC-W)|2016-12-29_PANEL_2_ZF_Group_one_F1652819_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-30_PANEL_2_ZF_Group_one_F1636242_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-30_PANEL_2_ZF_Group_one_F1636313_014|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-04_PANEL_2_DHS_Group_one_F1652841_001|manual
	NK CD56LO|2017-01-04_PANEL_2_DHS_Group_one_F1652841_001|manual
	NK CD56LO|2016-12-30_PANEL_2_HB_group_one_F1637136_002|manual
	DC (HLA-DR+)|2017_02_08_PANEL_2_ZF_group_two_F1653070_030|manual
	DC (HLA-DR+)|2016-12-29_PANEL_2_ZF_Group_one_F1637088_012|manual
	NK CD56LO|2016-12-29_PANEL_2_HB_group_one_F1637352_003|manual
	Classical monocytes (CD16- CD14+)|2017-01-04_PANEL_2_DHS_Group_two_F1635922_029|manual
	DC (HLA-DR+)|2017-01-04_PANEL_2_DHS_Group_one_F1635995_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017_02_08_PANEL_2_ZF_group_one_F1653097_013|manual
	Classical monocytes (CD16- CD14+)|2016-12-29_PANEL_2_ZF_Group_one_F1635662_001|manual
	NK CD56LO|2017-01-04_PANEL_2_DHS_Group_one_F1637349_007|manual
	CD14-|2016-12-29_PANEL_2_ZF_Group_one_F1636305_015|manual
	Classical monocytes (CD16- CD14+)|2017_02_08_PANEL_2_ZF_group_one_F1652662_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-12-30_PANEL_2_ZF_Group_one_F1635913_016|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-09_PANEL_2_DHS_Group_Four_ZF_F1638423_045|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_HB_Group_one_F1636035_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-05_PANEL_2_ZF_Group_one_F1636360_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-05_PANEL_2_ZF_Group_two_F1636032_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_DHS_Group_two_F1652828_027|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-01-10_PANEL_2_DHS_Group_one_F1636274_005|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-10_PANEL_2_HB_Group_one_F1636260_009|manual
	DC (HLA-DR+)|2017-01-05_PANEL_2_ZF_Group_two_F1631002_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_DHS_Group_two_F1636270_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-09_PANEL_2_DHS_Group_two_F1638754_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_DHS_Group_two_F1638573_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_DHS_Group_one_F1638509_002|manual
	NK CD56LO|2017-01-10_PANEL_2_HB_Group_one_F1635992_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-09_PANEL_2_DHS_Group_one_F1636278_007|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-06_PANEL_2_HB_group_two_F1636253_027|manual
	DC (HLA-DR+)|2017-01-09_PANEL_2_DHS_Group_Four_ZF_F1636280_047|manual
	DC (HLA-DR+)|2017-01-09_PANEL_2_DHS_Group_two_F1636171_031|manual
	NK CD56LO|2017-01-09_PANEL_2_DHS_Group_one_F1636412_004|manual
	DC (HLA-DR+)|2017-01-09_PANEL_2_DHS_Group_one_F1636412_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-06_PANEL_2_HB_group_one_F1636162_008|manual
	DC (HLA-DR+)|2017-01-05_PANEL_2_ZF_Group_two_F1636238_038|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-09_PANEL_2_DHS_Group_Three_ZF_F1638505_041|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_HB_Group_one_F1636000_004|manual
	CD14-|2017-01-05_PANEL_2_ZF_Group_two_F1636263_034|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-10_PANEL_2_DHS_Group_two_F1636030_031|manual
	NK CD56LO|2017-01-10_PANEL_2_HB_Group_two_F1638591_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-12_PANEL_2_ZF_Group_two_F1638669_026|manual
	NK CD56LO|2017-01-10_PANEL_2_HB_Group_Three_ZF_F1638557_037|manual
	CD14-|2017-01-12_PANEL_2_ZF_Group_two_F1635872_025|manual
	CD45+|2017-01-12_PANEL_2_HB_group_two_F1638569_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_HB_Group_two_F1638501_031|manual
	Classical monocytes (CD16- CD14+)|2017-01-12_PANEL_2_HB_group_three_F1652830_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-13_PANEL_2_HB_group_two_F1636267_031|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-10_PANEL_2_HB_Group_two_F1635809_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-13_PANEL_2_ZF_Group_one_F1638547_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-13_PANEL_2_HB_group_two_F1638424_030|manual
	DC (HLA-DR+)|2017-01-12_PANEL_2_HB_group_three_F1652558_037|manual
	NK CD56LO|2017-01-12_PANEL_2_HB_group_three_F1638580_042|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-10_PANEL_2_HB_Group_Three_ZF_F1638575_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-13_PANEL_2_HB_group_one_F1638544_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-12_PANEL_2_ZF_Group_one_F1635965_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-12_PANEL_2_HB_group_two_F1635962_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-20_PANEL_2_HB_group_one_F1635762_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-23_PANEL_2_DHS_Group_two_F1638437_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-17_PANEL_2_ZF_Group_one_F1652660_005|manual
	CD14-|2017-01-23_PANEL_2_DHS_Group_one_F1652577_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-18_PANEL_2_ZF_Group_two_F1638691_024|manual
	NK CD56LO|2017-01-18_PANEL_2_ZF_Group_two_F1652561_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-19_PANEL_2_ZF_Group_two_F1638740_024|manual
	DC NK (CD20- CD14-)|2017-01-17_PANEL_2_ZF_Group_two_HB_F1638718_031|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-17_PANEL_2_ZF_Group_two_HB_F1638718_031|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-17_PANEL_2_ZF_Group_two_F1638732_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-17_PANEL_2_ZF_Group_one_F1638504_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-23_PANEL_2_DHS_Group_two_F1637146_029|manual
	DC NK (CD20- CD14-)|2017-01-20_PANEL_2_ZF_Group_two_F1652605_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-20_PANEL_2_ZF_Group_two_F1652605_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-18_PANEL_2_ZF_Group_one_F1635808_004|manual
	CD14-|2017-01-18_PANEL_2_ZF_Group_one_F1635527_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-19_PANEL_2_ZF_Group_one_F1638632_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-18_PANEL_2_ZF_Group_two_F1638694_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-17_PANEL_2_ZF_Group_one_F1652645_003|manual
	Classical monocytes (CD16- CD14+)|2017-01-17_PANEL_2_ZF_Group_one_F1652645_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-20_PANEL_2_HB_group_one_F1637086_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-20_PANEL_2_HB_group_one_F1652671_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-23_PANEL_2_DHS_Group_one_F1652619_008|manual
	CD14-|2017-01-23_PANEL_2_DHS_Group_one_F1652619_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-18_PANEL_2_ZF_Group_one_F1652625_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-19_PANEL_2_ZF_Group_two_HB_F1638615_033|manual
	CD14-|2017-01-17_PANEL_2_ZF_Group_two_F1638528_026|manual
	NK CD56LO|2017-01-17_PANEL_2_ZF_Group_two_F1638531_027|manual
	CD14-|2017-01-27_PANEL_2_HB_group_two_F1637145_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-30_PANEL_2_DHS_Group_one_F1636185_004|manual
	CD14-|2017-01-30_PANEL_2_DHS_Group_one_F1636381_009|manual
	CD14-|2017-01-24_PANEL_2_ZF_group_one_F1637408_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-27_PANEL_2_HB_group_one_F1653112_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-24_PANEL_2_DHS_Group_two_F1638613_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-24_PANEL_2_DHS_Group_three_ZF_F1637161_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-24_PANEL_2_ZF_group_one_F1638554_001|manual
	DC (HLA-DR+)|2017-01-30_PANEL_2_DHS_Group_one_F1638742_015|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-26_PANEL_2_HB_group_one_Ctl-C_010|manual
	Classical monocytes (CD16- CD14+)|2017-01-24_PANEL_2_ZF_group_one_F1652664_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-24_PANEL_2_DHS_Group_one_F1638609_006|manual
	DC NK (CD20- CD14-)|2017-01-24_PANEL_2_ZF_group_two_Ctl-A_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-25_PANEL_2_ZF_group_one_F1636243_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-24_PANEL_2_DHS_Group_three_ZF_F1636380_030|manual
	NK CD56LO|2017-01-26_PANEL_2_ZF_Group_one_F1636369_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-1-03_PANEL_2_ZF_Group_two_F1637355_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-31_PANEL_2_DHS_Group_two_F1638535_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-30_PANEL_2_ZF_group_two_F1635830_026|manual
	DC (HLA-DR+)|2017-01-30_PANEL_2_DHS_Group_two_F1637365_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-30_PANEL_2_DHS_Group_two_F1637111_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-1-03_PANEL_2_ZF_Group_one_F1635954_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-01_PANEL_2_ZF_Group_one_F1635556_005|manual
	Classical monocytes (CD16- CD14+)|2017-02-01_PANEL_2_ZF_Group_one_F1635556_005|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-30_PANEL_2_DHS_Group_two_F1635796_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-30_PANEL_2_DHS_Group_two_F1637115_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-30_PANEL_2_ZF_group_one_F1638513_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-1-03_PANEL_2_ZF_Group_one_F1635942_002|manual
	DC NK (CD20- CD14-)|2017-01-31_PANEL_2_HB_group_two_F1652854_027|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-1-03_PANEL_2_ZF_Group_one_F1636026_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-01_PANEL_2_ZF_group_one_F1635814_014|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-1-03_PANEL_2_ZF_Group_two_F1649327_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-30_PANEL_2_DHS_Group_two_F1637411_030|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-30_PANEL_2_DHS_Group_two_F1636183_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-31_PANEL_2_HB_group_two_F1636371_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-01-30_PANEL_2_DHS_Group_two_Ctl-C_038|manual
	Classical monocytes (CD16- CD14+)|2017-02-01_PANEL_2_ZF_Group_one_F1652772_012|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-01-31_PANEL_2_HB_group_two_F1635707_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_DHS_Group_two_F1652803_032|manual
	DC (HLA-DR+)|2017-02-06_PANEL_2_DHS_group_two_F1652981_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_DHS_Group_one_F1652797_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-06_PANEL_2_DHS_group_one_F1638530_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_DHS_Group_one_F1652781_013|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-06_PANEL_2_ZF_Group_two_F1652998_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_DHS_Group_two_F1652644_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_DHS_Group_one_F1638521_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-03_PANEL_2_HB_group_one_F1652757_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-06_PANEL_2_ZF_Group_two_F1652808_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_HB_group_one_F1653071_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-03_PANEL_2_ZF_Group_two_F1652859_030|manual
	NK CD56LO|2017-02-03_PANEL_2_ZF_Group_two_F1652859_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_DHS_Group_two_F1653003_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-02_PANEL_2_ZF_Group_one_F1638746_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-06_PANEL_2_DHS_group_one_F1636348_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-07_PANEL_2_DHS_Group_one_F1652197_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-06_PANEL_2_ZF_Group_two_F1652198_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-06_PANEL_2_DHS_group_one_F1652858_007|manual
	DC (HLA-DR+)|2017-02-06_PANEL_2_DHS_group_one_F1652855_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-03_PANEL_2_HB_group_one_F1652764_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-03_PANEL_2_ZF_Group_one_F1635794_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-08_PANEL_2_ZF_Group_one_F1652542_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-13_PANEL_2_DHS_Group_one_F1652810_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-13_PANEL_2_DHS_Group_two_F1635491_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-08_PANEL_2_ZF_Group_two_F1653033_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-08_PANEL_2_ZF_Group_two_F1652971_038|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-09_PANEL_2_ZF_Group_one_F1652517_009|manual
	CD14-|2017-02-08_PANEL_2_ZF_Group_one_F1652572_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-09_PANEL_2_ZF_Group_two_F1635747_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-13_PANEL_2_ZF_group_one_F1652977_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-13_PANEL_2_DHS_Group_two_Ctl-A_042|manual
	CD14-|2017-02-14_PANEL_2_HB_Group_two_DHS_F1652938_025|manual
	CD45+|2017-02-15_PANEL_2_ZF_group_one_F1635470_009|manual
	NK CD56LO|2017-02-15_PANEL_2_ZF_group_one_F1635470_009|manual
	DC (HLA-DR+)|2017-02-15_PANEL_2_ZF_group_one_F1635470_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-14_PANEL_2_HB_Group_one_F1635756_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-16_PANEL_2_RR_Group_two_F1635432_025|manual
	NK CD56LO|2017-02-16_PANEL_2_RR_Group_one_Ctl-H_008|manual
	CD14-|2017-02-16_PANEL_2_RR_Group_one_Ctl-H_008|manual
	CD14-|2017-02-16_PANEL_2_RR_Group_one_F1652668_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-15_PANEL_2_ZF_Group_one_F1635471_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-14_PANEL_2_HB_Group_one_F1635686_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-13_PANEL_2_ZF_group_two_F1652500_028|manual
	NK CD56LO|2017-02-14_PANEL_2_HB_Group_one_F1653087_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-16_PANEL_2_RR_Group_two_F1652627_033|manual
	CD45+|2017-02-17_PANEL_2_RR_Group_one_F1635749_005|manual
	Classical monocytes (CD16- CD14+)|2017-02-17_PANEL_2_RR_Group_one_F1635749_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-13_PANEL_2_ZF_group_two_F1652956_027|manual
	NK CD56LO|2017-02-15_PANEL_2_ZF_group_one_F1653048_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-14_PANEL_2_HB_Group_two_DHS_F1653020_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-14_PANEL_2_HB_Group_two_DHS_F1653039_023|manual
	NK CD56LO|2017-02-15_PANEL_2_ZF_Group_two_F1635685_030|manual
	NK CD56LO|2017-02-14_PANEL_2_HB_Group_one_F1653009_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-16_PANEL_2_HB_group_one_F1635672_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-15_PANEL_2_ZF_group_one_F1635424_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-16_PANEL_2_RR_Group_one_F1653099_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-14_PANEL_2_DHS_group_one_F1653084_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-21_PANEL_2_DHS_Group_two_F1636809_026|manual
	Classical monocytes (CD16- CD14+)|2016-06-21_PANEL_2_DHS_Group_one_F1636782_012|manual
	Classical monocytes (CD16- CD14+)|2016-07-06_PANEL_2_ZF_Group_one_F1632325_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-23_PANEL_2_ZF_Group_two_F1632333_028|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-23_PANEL_2_ZF_Group_two_F1632333_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_one_F1636468_002|manual
	DC (HLA-DR+)|2016-06-22_PANEL_2_ZF_Group_one_F1636468_002|manual
	Live immune cells (CD45+ PE-)|2016-06-21_PANEL_2_DHS_Group_two_F1636848_030|manual
	CD14-|2016-06-22_PANEL_2_ZF_Group_two_F1631281_026|manual
	Classical monocytes (CD16- CD14+)|2016-06-28_PANEL_2_DHS_Group_one_F1631188_001|abnormal
	DC NK MONOCYTES (CD3- CD19-)|2016-06-22_PANEL_2_ZF_Group_two_F1632055_029|manual
	Classical monocytes (CD16- CD14+)|2016-06-28_PANEL_2_DHS_Group_one_F1632051_010|abnormal
	NK CD56LO|2016-06-22_PANEL_2_ZF_Group_two_F1632304_024|manual
	Classical monocytes (CD16- CD14+)|2016-06-27_PANEL_2_DHS_Group_one_F1632061_011|manual
	Classical monocytes (CD16- CD14+)|2016-06-27_PANEL_2_DHS_Group_one_F1632039_013|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-24_PANEL_2_ZF_Group_one_F1632322_007|manual
	Classical monocytes (CD16- CD14+)|2016-06-27_PANEL_2_DHS_Group_one_F1631341_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_two_Ctl-D_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-07_PANEL_2_ZF_Group_one_F1632359_006|manual
	NK CD56LO|2016-06-27_PANEL_2_DHS_Group_two_F1632042_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_one_F1649317_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_two_F1632317_030|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-22_PANEL_2_ZF_Group_two_F1632317_030|manual
	CD14-|2016-06-22_PANEL_2_ZF_Group_one_F1632316_008|manual
	Classical monocytes (CD16- CD14+)|2016-06-22_PANEL_2_ZF_Group_one_F1631021_009|manual
	NK CD56LO|2016-06-27_PANEL_2_DHS_Group_two_F1632320_031|manual
	Classical monocytes (CD16- CD14+)|2016-06-21_PANEL_2_DHS_Group_one_F1636795_008|manual
	NK CD56LO|2016-06-22_PANEL_2_ZF_Group_one_F1631015_010|manual
	Classical monocytes (CD16- CD14+)|2016-06-22_PANEL_2_ZF_Group_two_F1632046_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-20_PANEL_2_DHS_Group_two_Ctl-A_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-23_PANEL_2_ZF_Group_one_F1632309_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-22_PANEL_2_ZF_Group_two_F1652983_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-22_PANEL_2_ZF_Group_two_F1649819_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-23_PANEL_2_HB-newappsettings_group_one_PBMC-A_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-22_PANEL_2_ZF_Group_one_F1652400_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-20_PANEL_2_DHS_Group_one_F1652390_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-21_PANEL_2_ZF_Group_three_DHS_F1652410_036|manual
	Classical monocytes (CD16- CD14+)|2017-02-21_PANEL_2_DHS_group_one_F1652536_010|manual
	NK CD56LO|2017-02-22_PANEL_2_ZF_Group_two_Ctl_H_041|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-22_PANEL_2_ZF_Group_one_F1652795_007|manual
	Classical monocytes (CD16- CD14+)|2017-02-21_PANEL_2_ZF_Group_two_F1652980_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-22_PANEL_2_ZF_Group_one_F1638416_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-20_PANEL_2_DHS_Group_one_F1653100_013|manual
	NK CD56LO|2017-02-22_PANEL_2_ZF_Group_one_F1635761_014|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-21_PANEL_2_ZF_Group_one_F1652479_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-21_PANEL_2_ZF_Group_two_F1635790_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-22_PANEL_2_ZF_Group_one_F1652387_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-17_PANEL_2_ZF_group_one_F1635750_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-17_PANEL_2_ZF_group_two_F1652518_032|manual
	CD14-|2017-02-20_PANEL_2_DHS_Group_one_F1635462_015|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-21_PANEL_2_DHS_group_two_Ctl-B_036|manual
	NK CD56LO|2017-02-25_PANEL_2_DHS_Group_one_F1652477_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-24_PANEL_2_ZF_Group_one_F1635579_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-24_PANEL_2_RR_group_one_F1635691_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-24_PANEL_2_ZF_Group_one_F1652685_007|manual
	NK CD56LO|2017-02-28_PANEL_2_DHS_Group_two_F1653139_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_DHS_group_one_F1635720_002|manual
	NK CD56LO|2017-02-27_PANEL_2_ZF_Group_two_F1635728_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-24_PANEL_2_RR_group_one_F1653114_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_ZF_Group_one_F1652656_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_DHS_group_two_F1638805_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-24_PANEL_2_RR_group_two_F1635495_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_DHS_group_two_Ctl_C_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-24_PANEL_2_RR_group_one_F1635692_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_DHS_group_one_F1652487_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-28_PANEL_2_DHS_Group_two_F1638709_033|manual
	Classical monocytes (CD16- CD14+)|2017-02-25_PANEL_2_DHS_Group_one_F1653117_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-24_PANEL_2_ZF_Group_one_F1653130_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-25_PANEL_2_DHS_group_one_Ctl-C_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_DHS_group_two_F1636228_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-28_PANEL_2_RR_group_one_F1632073_002|manual
	Classical monocytes (CD16- CD14+)|2017-02-25_PANEL_2_DHS_Group_one_F1630991_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_ZF_Group_two_F1638663_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-27_PANEL_2_DHS_group_two_F1635727_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-03PANEL_2_LSR_RR_Group_two_F1638856_028|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-03PANEL_2_LSR_RR_Group_two_F1638856_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-03_PANEL_2_FORTESSA_ZF_group_one_F1634236_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-03PANEL_2_LSR_RR_Group_two_F1638843_026|manual
	DC (HLA-DR+)|2017-03-03PANEL_2_LSR_RR_Group_two_F1638843_026|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-03PANEL_2_LSR_RR_Group_two_F1638843_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-01_PANEL_2_FORTESSA_HB_group_two_Ctl-D_031|manual
	NK CD56LO|2017-03-03_PANEL_2_FORTESSA_ZF_group_two_F1638476_027|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-01_PANEL_2_FORTESSA_HB_group_two_F1638849_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-02_PANEL_2_FORTESSA_HB_group_one_F1638867_005|manual
	Classical monocytes (CD16- CD14+)|2017-03-02_PANEL_2_FORTESSA_HB_group_one_F1638867_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-03PANEL_2_LSR_RR_Group_two_F1633975_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-03PANEL_2_LSR_RR_Group_two_F1633975_029|manual
	CD14-|2017-03-02_PANEL_2_LSR_ZF_Group_one_F1638768_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-02_PANEL_2_FORTESSA_HB_group_two_ZF_F1638638_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-01_PANEL_2_LSR_ZF_Group_one_F1634183_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-02_PANEL_2_LSR_ZF_Group_one_F1638880_010|manual
	NK CD56LO|2017-03-03_PANEL_2_FORTESSA_ZF_group_one_F1638874_013|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-02-28_PANEL_2_RR_group_one_F1653169_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-03PANEL_2_LSR_RR_Group_two_F1638879_025|manual
	Classical monocytes (CD16- CD14+)|2017-03-03PANEL_2_LSR_RR_Group_one_F1638758_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-03PANEL_2_LSR_RR_Group_one_F1638755_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-01_PANEL_2_FORTESSA_HB_group_two_F1638645_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-06_PANEL_2_FORTESSA_DHS_group_one_F1633998_006|manual
	NK CD56LO|2017-03-02_PANEL_2_LSR_ZF_Group_one_F1635448_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-01_PANEL_2_LSR_ZF_Group_two_F1638832_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-01_PANEL_2_LSR_ZF_Group_two_Ctl-A_030|manual
	DC (HLA-DR+)|2017-03-07_PANEL_2_LSR_RR_Group_one_F1633925_008|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-07_PANEL_2_LSR_RR_Group_one_F1634193_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-07_PANEL_2_LSR_RR_Group_one_F1634246_001|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-07_PANEL_2_LSR_RR_Group_one_F1634246_001|manual
	Classical monocytes (CD16- CD14+)|2017-03-06_PANEL_2_FORTESSA_DHS_group_two_F1633990_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-07_PANEL_2_FORTESSA_DHS_group_one_F1638844_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-07_PANEL_2_FORTESSA_DHS_group_one_F1635689_008|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-07_PANEL_2_LSR_RR_Group_two_F1634234_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-06_PANEL_2_FORTESSA_DHS_group_one_F1638876_008|manual
	DC NK (CD20- CD14-)|2017-03-07_PANEL_2_LSR_RR_Group_one_F1633983_006|manual
	Classical monocytes (CD16- CD14+)|2017-03-07_PANEL_2_LSR_RR_Group_two_F1638785_028|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-07_PANEL_2_LSR_RR_Group_three_DHS_F1633952_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-06_PANEL_2_LSR_ZF_Group_one_F1638786_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-07_PANEL_2_FORTESSA_DHS_group_one_F1634020_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-10_PANEL_2_FORTESSA_RR_group_two_F1633927_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-06_PANEL_2_FORTESSA_DHS_group_one_F1636370_004|manual
	CD14-|2017-03-06_PANEL_2_FORTESSA_DHS_group_two_Ctl_H_041|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-07_PANEL_2_LSR_RR_Group_two_F1634241_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-08_PANEL_2_LSR_ZF_Group_one_F1633982_009|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-03-07_PANEL_2_LSR_RR_Group_three_DHS_F1638660_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-09_PANEL_2_FORTESSA_HB-post_tank_replacement_group_one_F1634025_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-15_PANEL_2_LSR_HB_Group_two_HRS035-WEEK2_027|manual
	Classical monocytes (CD16- CD14+)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1638007_016|manual
	Classical monocytes (CD16- CD14+)|2017-03-10_PANEL_2_LSR_ZF_Group_one_F1652224_005|manual
	CD14-|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1637944_005|manual
	Classical monocytes (CD16- CD14+)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1637944_005|manual
	CD45+|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1637955_014|manual
	Live immune cells (CD45+ PE-)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1637955_014|manual
	Classical monocytes (CD16- CD14+)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1638269_015|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-13_PANEL_2_LSR_RR_Group_two_F1638026_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-13_PANEL_2_LSR_RR_Group_two_F1638264_028|manual
	Classical monocytes (CD16- CD14+)|2017-03-13_PANEL_2_LSR_RR_Group_two_F1638264_028|manual
	DC (HLA-DR+)|2017-03-10_PANEL_2_LSR_ZF_Group_two_F1634225_031|manual
	Classical monocytes (CD16- CD14+)|2017-03-10_PANEL_2_LSR_ZF_Group_two_F1634225_031|manual
	Live immune cells (CD45+ PE-)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1638232_011|manual
	Classical monocytes (CD16- CD14+)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1638232_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-10_PANEL_2_LSR_ZF_Group_one_F1633917_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-10_PANEL_2_LSR_ZF_Group_one_F1633914_004|manual
	CD14-|2017-03-13_PANEL_2_LSR_RR_Group_two_F1633944_024|manual
	Live immune cells (CD45+ PE-)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1637948_004|manual
	Classical monocytes (CD16- CD14+)|2017-03-14_PANEL_2_LSR_HB_Group_one_F1638028_002|manual
	Live immune cells (CD45+ PE-)|2017-03-15_PANEL_2_FORTESSA_RR_group_two_F1637924_030|manual
	Classical monocytes (CD16- CD14+)|2017-03-15_PANEL_2_FORTESSA_RR_group_two_F1637924_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-20_PANEL_2_FORTESSA_HB_group_one_F1637983_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-15_PANEL_2_LSR_HB_Group_two_HRS039-WEEK2_031|manual
	Classical monocytes (CD16- CD14+)|2017-03-15_PANEL_2_FORTESSA_RR_group_two_F1638218_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-15_PANEL_2_LSR_HB_Group_two_HRS034-WEEK2_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-14_PANEL_2_LSR_HB_Group_one_F1638263_005|manual
	Classical monocytes (CD16- CD14+)|2017-03-16_PANEL_2_FORTESSA_HB_group_one_F1637917_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-23_PANEL_2_LSR_ZF_Group_one_F1634318_010|manual
	DC (HLA-DR+)|2017-03-23_PANEL_2_FORTESSA_HB_group_one_F1637921_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-21_PANEL_2_LSR_RR_Group_two_F1635742_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-23_PANEL_2_FORTESSA_HB_group_one_F1634363_005|manual
	NK CD56LO|2017-03-23_PANEL_2_LSR_ZF_Group_two_F1634044_032|manual
	NK CD56LO|2017-03-23_PANEL_2_LSR_ZF_Group_two_F1634060_036|manual
	NK CD56LO|2017-03-21_PANEL_2_FORTESSA_DHS_group_one_F1652654_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-20_PANEL_2_LSR_ZF_Group_one_F1638664_005|manual
	DC (HLA-DR+)|2017-03-20_PANEL_2_LSR_ZF_Group_one_F1638664_005|manual
	CD45+|2017-03-21_PANEL_2_LSR_RR_Group_three_DHS_F1638179_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-21_PANEL_2_LSR_RR_Group_three_DHS_F1638179_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-21_PANEL_2_LSR_RR_Group_two_F1634326_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-21_PANEL_2_LSR_RR_Group_two_F1638177_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-20_PANEL_2_LSR_ZF_Group_one_F1637933_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-23_PANEL_2_LSR_ZF_Group_two_F1638875_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-20_PANEL_2_LSR_ZF_Group_one_F1637982_007|manual
	Classical monocytes (CD16- CD14+)|2017-03-20_PANEL_2_LSR_ZF_Group_one_F1637982_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-20_PANEL_2_LSR_ZF_Group_one_F1634293_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-20_PANEL_2_LSR_ZF_Group_two_F1634042_032|manual
	NK CD56LO|2017-03-21_PANEL_2_LSR_RR_Group_one_F1638183_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-21_PANEL_2_LSR_RR_Group_two_F1637981_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-20_PANEL_2_LSR_ZF_Group_two_F1652413_031|manual
	Classical monocytes (CD16- CD14+)|2017-03-20_PANEL_2_LSR_ZF_Group_two_F1652413_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-23_PANEL_2_LSR_ZF_Group_two_HB_F1634067_043|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-27_PANEL_2_FORTESSA_DHS_group_two_Ctl-H_038|manual
	DC (HLA-DR+)|2017-03-27_PANEL_2_FORTESSA_DHS_group_two_Ctl-H_038|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-27_PANEL_2_LSR_HB_Group_one_F1634325_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-28_PANEL_2_LSR_RR_Group_two_F1642928_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-23_PANEL_2_LSR_ZF_Group_two_HB_F1634048_041|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-24_PANEL_2_LSR_RR_Group_one_F1638170_003|manual
	CD14-|2017-03-28_PANEL_2_LSR_RR_Group_two_F1634143_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-30_PANEL_2_FORTESSA_HB_group_one_F1634132_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-27_PANEL_2_LSR_HB_Group_two_DHS_F1653079_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-27_PANEL_2_LSR_HB_Group_one_F1638053_005|manual
	NK CD56LO|2017-03-27_PANEL_2_LSR_HB_Group_one_F1638053_005|manual
	NK CD56LO|2017-03-28_PANEL_2_LSR_RR_Group_one_F1634093_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-23_PANEL_2_LSR_ZF_Group_two_HB_F1634003_042|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-24_PANEL_2_FORTESSA_HB_group_one_F1634309_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-24_PANEL_2_FORTESSA_HB_group_two_F1634399_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-24_PANEL_2_LSR_RR_Group_one_F1634125_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-24_PANEL_2_FORTESSA_HB_group_one_F1634041_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-29_PANEL_2_FORTESSA_HB_group_one_F1634411_002|manual
	NK CD56LO|2017-03-27_PANEL_2_LSR_HB_Group_one_F1638279_006|manual
	CD14-|2017-03-27_PANEL_2_LSR_HB_Group_one_F1638279_006|manual
	Classical monocytes (CD16- CD14+)|2017-03-27_PANEL_2_LSR_HB_Group_one_F1638279_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-28_PANEL_2_LSR_RR_Group_one_F1638214_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-23_PANEL_2_LSR_ZF_Group_two_HB_F1634194_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-28_PANEL_2_FORTESSA_DHS_group_one_F1638851_014|manual
	Classical monocytes (CD16- CD14+)|2017-03-24_PANEL_2_FORTESSA_HB_group_two_F1638300_029|manual
	NK CD56LO|2017-03-30_PANEL_2_FORTESSA_HB_group_two_F1634111_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-31_PANEL_2_LSR_HB_Group_one_F1634148_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-30_PANEL_2_LSR_RR_Group_two_F1638332_033|manual
	Classical monocytes (CD16- CD14+)|2017-04-03_PANEL_2_LSR_DHS_Group_three_F1636186_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-30_PANEL_2_FORTESSA_HB_group_two_F1634390_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-31_PANEL_2_LSR_HB_Group_two_F1640641_034|manual
	CD14-|2017-04-03_PANEL_2_FORTESSA_DHS_group_three_F1638292_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-31_PANEL_2_FORTESSA_RR_group_one_F1634283_007|manual
	Classical monocytes (CD16- CD14+)|2017-03-31_PANEL_2_FORTESSA_RR_group_one_F1634283_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-03_PANEL_2_LSR_DHS_Group_three_F1640846_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-31_PANEL_2_FORTESSA_RR_group_two_F1642800_025|manual
	NK CD56LO|2017-03-31_PANEL_2_LSR_HB_Group_one_F1634159_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-03_PANEL_2_LSR_DHS_Group_two_F1642937_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-30_PANEL_2_LSR_RR_Group_two_F1634033_027|manual
	NK CD56LO|2017-03-30_PANEL_2_LSR_RR_Group_two_F1642795_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-03-31_PANEL_2_LSR_HB_Group_one_F1638317_003|manual
	NK CD56LO|2017-03-31_PANEL_2_LSR_HB_Group_two_F1638296_029|manual
	Live immune cells (CD45+ PE-)|2017-04-05_PANEL_2_LSR_HB_Group_three_F1642915_029|manual
	CD14-|2017-04-07_PANEL_2_LSR_RR_Group_two_F1640788_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-04_PANEL_2_LSR_RR_Group_two_Ctl-H_040|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-05_PANEL_2_LSR_HB_Group_two_F1640500_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-10_PANEL_2_FORTESSA_DHS_group_one_F1638163_005|manual
	Classical monocytes (CD16- CD14+)|2017-04-04_PANEL_2_LSR_RR_Group_two_F1640894_039|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-04-05_PANEL_2_LSR_HB_Group_one_F1642917_001|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-04-05_PANEL_2_FORTESSA_HB_group_one_F1640877_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-04_PANEL_2_LSR_RR_Group_one_F1640658_008|manual
	DC NK (CD20- CD14-)|2017-04-04_PANEL_2_LSR_RR_Group_two_F1640741_034|manual
	NK CD56LO|2017-04-06_PANEL_2_FORTESSA_HB_group_three_F1638219_029|manual
	Classical monocytes (CD16- CD14+)|2017-04-05_PANEL_2_LSR_HB_Group_two_F1640633_026|manual
	CD14-|2017-04-06_PANEL_2_FORTESSA_HB_group_three_F1640515_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-10_PANEL_2_FORTESSA_DHS_group_one_F1642846_001|manual
	CD14-|2017-04-05_PANEL_2_LSR_HB_Group_two_F1640882_025|manual
	Classical monocytes (CD16- CD14+)|2017-04-10_PANEL_2_LSR_DHS_Group_one_F1640652_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-07_PANEL_2_LSR_RR_Group_two_F1642898_026|manual
	Classical monocytes (CD16- CD14+)|2017-04-07_PANEL_2_LSR_RR_Group_two_F1642898_026|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-04-05_PANEL_2_FORTESSA_HB_group_one_F1640904_002|manual
	Classical monocytes (CD16- CD14+)|2017-04-04_PANEL_2_LSR_RR_Group_one_F1640621_009|manual
	Classical monocytes (CD16- CD14+)|2017-04-13_PANEL_2_LSR_HB_Group_one_F1642830_007|Manual
	NK CD56LO|2017-04-11_PANEL_2_LSR_RR_Group_two_F1642897_031|Manual
	Classical monocytes (CD16- CD14+)|2017-04-11_PANEL_2_LSR_RR_Group_two_F1642897_031|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-13_PANEL_2_FORTESSA_HB_group_one_F1642612_003|Manual
	Classical monocytes (CD16- CD14+)|2017-04-13_PANEL_2_LSR_HB_Group_two_F1642984_023|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-12_PANEL_2_LSR_ZF_Group_two_F1642908_024|Manual
	Classical monocytes (CD16- CD14+)|2017-04-13_PANEL_2_FORTESSA_HB_group_four_F1642665_036|Manual
	CD14-|2017-04-12_PANEL_2_LSR_ZF_Group_two_F1642833_027|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-13_PANEL_2_LSR_HB_Group_two_F1642623_021|Manual
	NK CD56LO|2017-04-10_PANEL_2_LSR_DHS_Group_two_F1640909_022|Manual
	CD14-|2017-04-10_PANEL_2_LSR_DHS_Group_two_F1640909_022|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-10_PANEL_2_LSR_DHS_Group_three_F1642645_031|Manual
	Classical monocytes (CD16- CD14+)|2017-04-11_PANEL_2_LSR_RR_Group_two_F1642905_028|Manual
	Classical monocytes (CD16- CD14+)|2017-04-12_PANEL_2_LSR_ZF_Group_one_F1642622_001|Manual
	NK CD56LO|2017-04-11_PANEL_2_LSR_RR_Group_two_F1642816_032|Manual
	CD14-|2017-04-11_PANEL_2_LSR_RR_Group_two_F1642816_032|Manual
	Classical monocytes (CD16- CD14+)|2017-04-11_PANEL_2_LSR_RR_Group_two_F1642816_032|Manual
	Classical monocytes (CD16- CD14+)|2017-04-11_PANEL_2_LSR_RR_Group_two_F1640576_035|Manual
	Classical monocytes (CD16- CD14+)|2017-04-13_PANEL_2_LSR_HB_Group_four_F1638005_041|Manual
	Classical monocytes (CD16- CD14+)|2017-04-13_PANEL_2_FORTESSA_HB_group_four_F1642902_040|Manual
	NK CD56LO|2017-04-11_PANEL_2_FORTESSA_DHS_group_two_F1640761_033|Manual
	DC (HLA-DR+)|2017-04-11_PANEL_2_FORTESSA_DHS_group_two_F1640761_033|Manual
	DC (HLA-DR+)|2017-04-13_PANEL_2_LSR_HB_Group_four_F1642985_040|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-13_PANEL_2_FORTESSA_HB_group_two_F1642663_025|Manual
	CD14-|2017-04-10_PANEL_2_LSR_DHS_Group_two_F1649333_024|Manual
	NK CD56LO|2017-04-13_PANEL_2_LSR_HB_Group_three_F1643009_031|Manual
	NK CD56LO|2017-04-13_PANEL_2_FORTESSA_HB_group_three_F1635907_032|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-12_PANEL_2_LSR_ZF_Group_one_F1638008_005|Manual
	CD14-|2017-04-10_PANEL_2_LSR_DHS_Group_two_F1642910_021|Manual
	NK CD56LO|2017-04-11_PANEL_2_FORTESSA_DHS_group_one_F1642638_008|Manual
	DC NK (CD20- CD14-)|2017-04-11_PANEL_2_LSR_RR_Group_one_F1642996_006|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-04-11_PANEL_2_LSR_RR_Group_one_F1642996_006|Manual
	Classical monocytes (CD16- CD14+)|2017-04-11_PANEL_2_LSR_RR_Group_two_F1642982_034|Manual
	NK CD56LO|2016-06-07_PANEL_2_DHS_Group_one_F1632269_008|manual
	DC (HLA-DR+)|2016-06-07_PANEL_2_DHS_Group_one_F1632269_008|manual
	NK CD56LO|2016-06-17_PANEL_2_ZF_Group_two_F1632303_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-06_PANEL_2_DHS_Group_two_F1632247_026|manual
	DC (HLA-DR+)|2016-06-14_PANEL_2_DHS_Group_one_F1631970_010|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-17_PANEL_2_ZF_Group_one_F1632195_001|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-17_PANEL_2_ZF_Group_two_F1632302_028|manual
	NK CD56LO|2016-06-08_PANEL_2_ZF_Group_two_F1631033_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-09_PANEL_2_ZF_Group_two_Ctl-C_032|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-09_PANEL_2_ZF_Group_two_Ctl-C_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-10_PANEL_2_ZF_Group_one_F1636742_008|manual
	Classical monocytes (CD16- CD14+)|2016-06-17_PANEL_2_ZF_Group_two_F1631277_024|manual
	Classical monocytes (CD16- CD14+)|2016-06-07_PANEL_2_DHS_Group_one_F1631352_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-07_PANEL_2_DHS_Group_two_F1631035_026|manual
	DC (HLA-DR+)|2016-06-07_PANEL_2_DHS_Group_two_F1631035_026|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-07_PANEL_2_DHS_Group_two_F1631035_026|manual
	NK CD56LO|2016-05-26_PANEL_2_ZF_panel_2_F1631120_013|manual
	CD14-|2016-06-06_PANEL_2_DHS_Group_two_F1632202_028|manual
	Classical monocytes (CD16- CD14+)|2016-06-07_PANEL_2_DHS_Group_two_F1631060_028|manual
	NK CD56LO|2016-06-09_PANEL_2_ZF_Group_one_F1631046_001|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-05-27_PANEL_2_ZF_panel_2_F1631031_005|manual
	DC (HLA-DR+)|2016-06-13_PANEL_2_DHS_Group_one_F1636731_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-09_PANEL_2_ZF_Group_one_F1631315_008|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-09_PANEL_2_ZF_Group_one_F1631315_008|manual
	NK CD56LO|2016-06-17_PANEL_2_ZF_Group_two_F1632035_026|manual
	NK CD56LO|2016-05-26_PANEL_2_ZF_panel_2_F1631133_003|manual
	CD45+|2016-05-26_PANEL_2_ZF_panel_2_F1636727_014|manual
	NK CD56LO|2016-05-26_PANEL_2_ZF_panel_2_F1636727_014|manual
	Classical monocytes (CD16- CD14+)|2016-06-17_PANEL_2_ZF_Group_one_F1632321_006|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-08_PANEL_2_ZF_Group_two_F1632264_031|manual
	NK CD56LO|2016-06-17_PANEL_2_ZF_Group_two_F1632021_027|manual
	Classical monocytes (CD16- CD14+)|2016-06-17_PANEL_2_ZF_Group_two_F1632021_027|manual
	CD14-|2016-05-31_PANEL_2_DHS_panel_2_PBMC-A_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-13_PANEL_2_DHS_Group_one_F1636732_003|manual
	NK CD56LO|2016-06-13_PANEL_2_DHS_Group_one_F1636732_003|manual
	Classical monocytes (CD16- CD14+)|2016-06-13_PANEL_2_DHS_Group_one_F1636732_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-08_PANEL_2_ZF_Group_two_Ctl-D_032|manual
	NK CD56LO|2016-06-07_PANEL_2_DHS_Group_two_F1631038_030|manual
	Classical monocytes (CD16- CD14+)|2016-06-07_PANEL_2_DHS_Group_two_F1631038_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-07_PANEL_2_DHS_Group_two_F1631038_030|manual
	CD14-|2016-05-29_PANEL_2_HB_panel_2_G_D1_004|manual
	NK CD56LO|2016-06-07_PANEL_2_DHS_Group_one_F1631313_001|manual
	Classical monocytes (CD16- CD14+)|2016-06-07_PANEL_2_DHS_Group_one_F1631313_001|manual
	NK CD56LO|2016-06-03_PANEL_2_ZF_Group_two_F1631037_024|manual
	CD14-|2016-05-31_PANEL_2_DHS_panel_2_F1631998_008|manual
	CD45+|2016-05-29_PANEL_2_HB_panel_2_H_D3_003|manual
	NK CD56LO|2016-05-29_PANEL_2_HB_panel_2_H_D3_003|manual
	DC NK (CD20- CD14-)|2016-05-29_PANEL_2_HB_panel_2_H_D3_003|manual
	Classical monocytes (CD16- CD14+)|2016-05-29_PANEL_2_HB_panel_2_H_D3_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-15_PANEL_2_ZF_Group_two_F1636479_031|manual
	NK CD56LO|2016-06-08_PANEL_2_ZF_Group_two_F1631121_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-15_PANEL_2_ZF_Group_two_Ctl-A_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-07_PANEL_2_DHS_Group_two_Ctl-C_032|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-09_PANEL_2_ZF_Group_two_F1631342_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-09_PANEL_2_ZF_Group_two_F1636746_029|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-09_PANEL_2_ZF_Group_two_F1636746_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-06_PANEL_2_DHS_Group_two_Ctl-D_032|manual
	Classical monocytes (CD16- CD14+)|2016-06-06_PANEL_2_DHS_Group_two_Ctl-D_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-14_PANEL_2_DHS_Group_one_F1636492_003|manual
	NK CD56LO|2016-06-17_PANEL_2_ZF_Group_one_F1632095_007|manual
	NK CD56LO|2016-06-03_PANEL_2_ZF_Group_one_F1631067_003|manual
	Classical monocytes (CD16- CD14+)|2016-06-08_PANEL_2_ZF_Group_two_F1631349_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-08_PANEL_2_ZF_Group_two_F1631349_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-10_PANEL_2_ZF_Group_one_Ctl-A_010|manual
	NK CD56LO|2016-06-06_PANEL_2_DHS_Group_one_F1631963_001|manual
	Classical monocytes (CD16- CD14+)|2016-06-06_PANEL_2_DHS_Group_one_F1631963_001|manual
	NK CD56LO|2016-06-14_PANEL_2_DHS_Group_two_F1631155_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-07_PANEL_2_DHS_Group_two_F1632272_029|manual
	DC (HLA-DR+)|2016-06-20_PANEL_2_DHS_Group_one_F1632032_008|manual
	NK CD56LO|2016-06-10_PANEL_2_ZF_Group_one_F1636759_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-06_PANEL_2_DHS_Group_two_F1631986_024|manual
	CD14-|2016-06-09_PANEL_2_ZF_Group_one_F1631050_003|manual
	Classical monocytes (CD16- CD14+)|2016-06-09_PANEL_2_ZF_Group_one_F1631050_003|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-07_PANEL_2_DHS_Group_two_F1631339_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-03_PANEL_2_ZF_Group_one_F1631019-bad_008|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-07_PANEL_2_DHS_Group_two_F1631020_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-20_PANEL_2_DHS_Group_one_F1632318_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-09_PANEL_2_ZF_Group_one_F1632296_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-17_PANEL_2_ZF_Group_one_F1632291_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-03_PANEL_2_ZF_Group_one_F1631053_005|manual
	NK CD56LO|2016-05-26_PANEL_2_ZF_panel_2_F1631064_001|manual
	Classical monocytes (CD16- CD14+)|2016-05-26_PANEL_2_ZF_panel_2_F1631064_001|manual
	NK CD56LO|2016-06-06_PANEL_2_DHS_Group_two_F1631973_029|manual
	DC (HLA-DR+)|2016-06-06_PANEL_2_DHS_Group_two_F1631973_029|manual
	CD14-|2016-06-06_PANEL_2_DHS_Group_two_F1631973_029|manual
	Classical monocytes (CD16- CD14+)|2016-06-06_PANEL_2_DHS_Group_two_F1631973_029|manual
	NK CD56LO|2016-06-09_PANEL_2_ZF_Group_one_F1631048_009|manual
	NK CD56LO|2016-06-08_PANEL_2_ZF_Group_one_F1631043_005|manual
	CD14-|2016-06-06_PANEL_2_DHS_Group_one_F1631979_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-15_PANEL_2_ZF_Group_one_F1636487_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-20_PANEL_2_DHS_Group_one_F1632307_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-05-31_PANEL_2_DHS_panel_2_Ctl-C_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-09_PANEL_2_ZF_Group_two_F1631980_026|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-09_PANEL_2_ZF_Group_two_F1631980_026|manual
	NK CD56LO|2016-06-07_PANEL_2_DHS_Group_one_F1631123_011|manual
	CD14-|2016-06-07_PANEL_2_DHS_Group_one_F1631123_011|manual
	Classical monocytes (CD16- CD14+)|2016-06-07_PANEL_2_DHS_Group_one_F1631123_011|manual
	NK CD56LO|2016-06-17_PANEL_2_ZF_Group_one_F1632060_010|manual
	DC (HLA-DR+)|2016-06-08_PANEL_2_ZF_Group_one_F1632319_008|manual
	NK CD56LO|2016-05-26_PANEL_2_ZF_panel_2_F1636717_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-05-27_PANEL_2_ZF_panel_2_Ctl-C_015|manual
	CD14-|2016-06-15_PANEL_2_ZF_Group_two_F1636753_023|manual
	NK CD56LO|2016-05-27_PANEL_2_ZF_panel_2_F1631355_009|manual
	Classical monocytes (CD16- CD14+)|2016-05-27_PANEL_2_ZF_panel_2_F1631355_009|manual
	NK CD56LO|2016-06-07_PANEL_2_DHS_Group_two_F1631350_024|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-08_PANEL_2_ZF_Group_one_F1632025_001|manual
	NK CD56LO|2016-06-20_PANEL_2_DHS_Group_one_F1632040_003|manual
	CD14-|2016-05-31_PANEL_2_DHS_panel_2_F1632004_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-03_PANEL_2_ZF_Group_two_F1631317_026|manual
	NK CD56LO|2016-06-03_PANEL_2_ZF_Group_two_F1631317_026|manual
	DC NK (CD20- CD14-)|2016-06-03_PANEL_2_ZF_Group_two_F1631317_026|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-03_PANEL_2_ZF_Group_two_F1631317_026|manual
	CD14-|2016-05-31_PANEL_2_DHS_panel_2_F1632179_006|manual
	DC (HLA-DR+)|2016-06-06_PANEL_2_DHS_Group_two_F1636496_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-14_PANEL_2_DHS_Group_one_F1636729_005|manual
	Classical monocytes (CD16- CD14+)|2016-05-29_PANEL_2_HB_panel_2_F_D3_009|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-06-06_PANEL_2_DHS_Group_one_F1631969_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_ZF-WB_24HRS_009|manual
	NK CD56LO|2017-04-19_PANEL_2_FORTESSA_HB_group_one_ZF-WB_24HRS_009|manual
	Live immune cells (CD45+ PE-)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_ZF-WB_24HRS_009|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_ZF-WB_24HRS_009|manual
	Classical monocytes (CD16- CD14+)|2017-04-14_PANEL_2_LSR_RR_Group_one_F1642766_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-14_PANEL_2_FORTESSA_RR_group_one_F1642631_003|manual
	NK CD56LO|2017-04-14_PANEL_2_FORTESSA_RR_group_one_F1642631_003|manual
	Live immune cells (CD45+ PE-)|2017-04-18_PANEL_2_FORTESSA_HB_group_one_RR-WB-D0_002|manual
	Classical monocytes (CD16- CD14+)|2017-04-14_PANEL_2_FORTESSA_RR_group_one_F1642773_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-14_PANEL_2_LSR_RR_Group_one_F1643000_005|manual
	Classical monocytes (CD16- CD14+)|2017-04-14_PANEL_2_LSR_RR_Group_one_F1643000_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-19_PANEL_2_LSR_ZF_Group_two_F1640721_019|manual
	Classical monocytes (CD16- CD14+)|2017-04-19_PANEL_2_LSR_ZF_Group_two_F1640721_019|manual
	NK CD56LO|2017-04-14_PANEL_2_LSR_RR_Group_one_F1638051_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-17_PANEL_2_LSR_DHS_Group_one_F1642969_007|manual
	Classical monocytes (CD16- CD14+)|2017-04-17_PANEL_2_LSR_DHS_Group_one_F1642969_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_RR-WB_24HRS_008|manual
	Live immune cells (CD45+ PE-)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_RR-WB_24HRS_008|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_RR-WB_24HRS_008|manual
	Classical monocytes (CD16- CD14+)|2017-04-17_PANEL_2_FORTESSA_DHS_group_two_F1642544_025|manual
	NK CD56LO|2017-04-14_PANEL_2_LSR_RR_Group_two_F1637918_020|manual
	Classical monocytes (CD16- CD14+)|2017-04-14_PANEL_2_LSR_RR_Group_one_F1649350_003|manual
	CD14-|2017-04-18_PANEL_2_FORTESSA_RR_group_two_F1640677_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_BC-WB_24HRS_007|manual
	Live immune cells (CD45+ PE-)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_BC-WB_24HRS_007|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-04-19_PANEL_2_FORTESSA_HB_group_one_BC-WB_24HRS_007|manual
	Classical monocytes (CD16- CD14+)|2017-04-14_PANEL_2_LSR_RR_Group_one_F1642998_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-17_PANEL_2_FORTESSA_DHS_group_two_F1642768_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-17_PANEL_2_LSR_DHS_Group_one_F1638313_006|manual
	NK CD56LO|2017-04-14_PANEL_2_LSR_RR_Group_one_F1643012_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-17_PANEL_2_LSR_DHS_Group_one_F1642671_010|manual
	NK CD56LO|2017-04-14_PANEL_2_FORTESSA_RR_group_one_F1640907_006|manual
	Classical monocytes (CD16- CD14+)|2017-04-14_PANEL_2_FORTESSA_RR_group_one_F1640907_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-19_PANEL_2_LSR_ZF_group_three_F1642749_032|manual
	Classical monocytes (CD16- CD14+)|2017-04-19_PANEL_2_LSR_ZF_group_three_F1642749_032|manual
	CD45+|2017-04-14_PANEL_2_FORTESSA_RR_group_two_F1642876_027|manual
	Classical monocytes (CD16- CD14+)|2017-04-14_PANEL_2_FORTESSA_RR_group_two_F1642876_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-18_PANEL_2_FORTESSA_RR_group_two_F1642740_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-17_PANEL_2_FORTESSA_DHS_group_two_F1642890_028|manual
	Live immune cells (CD45+ PE-)|2017-04-18_PANEL_2_FORTESSA_HB_group_one_ZF-WB-D0_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-19_PANEL_2_LSR_ZF_group_three_F1640699_030|manual
	Classical monocytes (CD16- CD14+)|2017-04-19_PANEL_2_LSR_ZF_group_three_F1640699_030|manual
	Live immune cells (CD45+ PE-)|2017-04-18_PANEL_2_FORTESSA_HB_group_one_BC-WB-D0_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-20_PANEL_2_FORTESSA_ZF_group_two_F1642746_005|manual
	NK CD56LO|2017-04-20_PANEL_2_LSR_ZF_Group_one_F1642543_013|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-20_PANEL_2_LSR_ZF_Group_two_Ctl_G_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-24_PANEL_2_FORTESSA_DHS_group_two_Ctl_H_038|manual
	NK CD56LO|2017-04-24_PANEL_2_LSR_ZF_Group_one_ZF_F1640495_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-20_PANEL_2_LSR_ZF_Group_one_F1642567_005|manual
	Classical monocytes (CD16- CD14+)|2017-04-20_PANEL_2_LSR_ZF_Group_one_F1640774_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-24_PANEL_2_LSR_ZF_Group_one_ZF_F1640786_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_FORTESSA_HB_group_one_ZF_CPT_0_017|manual
	CD14-|2017-04-20_PANEL_2_FORTESSA_ZF_group_two_F1642593_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-24_PANEL_2_LSR_ZF_Group_one_DHS_F1640548_003|manual
	CD14-|2017-04-24_PANEL_2_LSR_ZF_Group_two_ZF_F1640710_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-24_PANEL_2_FORTESSA_DHS_group_one_F1642938_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-21_PANEL_2_LSR_ZF_Group_two_F1640668_021|manual
	Classical monocytes (CD16- CD14+)|2017-04-21_PANEL_2_LSR_ZF_Group_two_F1640668_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-24_PANEL_2_LSR_ZF_Group_two_ZF_F1640603_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-24_PANEL_2_LSR_ZF_Group_two_ZF_F1640547_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-24_PANEL_2_FORTESSA_DHS_group_two_F1642687_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_LSR_DHS_Group_one_F1638181_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_LSR_DHS_Group_one_F1640828_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_LSR_DHS_Group_one_F1640815_007|manual
	DC (HLA-DR+)|2017-04-26_PANEL_2_FORTESSA_ZF_group_one_F1640830_001|Manual
	NK CD56LO|2017-04-25_PANEL_2_LSR_DHS_Group_two_F1643010_036|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_LSR_DHS_Group_two_F1640454_039|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-27_PANEL_2_LSR_RR_Group_two_Ctl-F_001|Manual
	Classical monocytes (CD16- CD14+)|2017-04-25-26-27_PANEL_2_FORTESSA_HB_2017-04-25_ZF_CPT_24_014|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_LSR_DHS_Group_two_F1640818_037|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-27_PANEL_2_FORTESSA_ZF_group_one_ZF_F1640469_022|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_LSR_DHS_Group_two_F1640717_035|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-27_PANEL_2_LSR_RR_Group_two_RR_Ctl-F_026|Manual
	Classical monocytes (CD16- CD14+)|2017-04-25-26_PANEL_2_FORTESSA_HB_2017-04-25_ZF_CPT_24_014|Manual
	DC NK (CD20- CD14-)|2017-04-27_PANEL_2_LSR_RR_Group_one_RR_F1640715_003|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-26_PANEL_2_LSR_ZF_Group_one_F1640418_008|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-25_PANEL_2_LSR_DHS_Group_three_F1640456_043|Manual
	NK CD56LO|2017-04-28_PANEL_2_LSR_ZF_Group_one_F1640803_004|Manual
	Classical monocytes (CD16- CD14+)|2017-04-28_PANEL_2_LSR_ZF_Group_one_F1640803_004|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-26_PANEL_2_LSR_ZF_Group_three_F1640821_028|Manual
	Classical monocytes (CD16- CD14+)|2017-04-25-26_PANEL_2_FORTESSA_HB_2017-04-25_RR_CPT_24_012|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-28_PANEL_2_LSR_ZF_Group_one_F1640663_009|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-26_PANEL_2_LSR_ZF_Group_three_F1642711_030|Manual
	NK CD56LO|2017-04-26_PANEL_2_FORTESSA_ZF_group_three_F1640481_030|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-01_PANEL_2_LSR_ZF_Group_four_DHS_F1641484_041|manual
	Classical monocytes (CD16- CD14+)|2017-05-04_PANEL_2_FORTESSA_ZF_group_one_F1641773_004|manual
	DC NK (CD20- CD14-)|2017-05-02_PANEL_2_FORTESSA_DHS_group_one_F1642023_012|manual
	Classical monocytes (CD16- CD14+)|2017-05-03_PANEL_2_LSR_ZF_Group_three_F1642940_026|manual
	Classical monocytes (CD16- CD14+)|2017-05-03_PANEL_2_FORTESSA_ZF_group_one_F1641990_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-01_PANEL_2_LSR_ZF_Group_one_ZF_F1641926_003|manual
	DC NK (CD20- CD14-)|2017-05-02_PANEL_2_FORTESSA_DHS_group_one_F1641992_009|manual
	DC NK (CD20- CD14-)|2017-05-02_PANEL_2_FORTESSA_DHS_group_one_RR_F1641862_036|manual
	Classical monocytes (CD16- CD14+)|2017-05-04_PANEL_2_FORTESSA_ZF_group_one_F1640597_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-01_PANEL_2_LSR_ZF_Group_three_DHS_F1642712_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-01_PANEL_2_LSR_ZF_Group_two_Ctl-F_038|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-04-28_PANEL_2_LSR_ZF_Group_two_F1640697_030|manual
	Classical monocytes (CD16- CD14+)|2017-05-02_PANEL_2_LSR_RR_Group_two_F1641483_023|manual
	Classical monocytes (CD16- CD14+)|2017-05-02_PANEL_2_LSR_RR_Group_two_F1641495_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-01_PANEL_2_LSR_ZF_Group_two_F1642722_024|manual
	CD14-|2017-05-04_PANEL_2_LSR_RR_Group_one_F1641473_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-08_PANEL_2_LSR_DHS_Group_one_F1640601_009|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-05-08_PANEL_2_LSR_DHS_Group_two_F1642008_040|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-04_PANEL_2_LSR_RR_Group_two_Ctl-G_033|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_one_F1642604_010|manual
	Classical monocytes (CD16- CD14+)|2017-05-05_PANEL_2_LSR_RR_Group_one_F1642725_006|manual
	Classical monocytes (CD16- CD14+)|2017-05-04_PANEL_2_LSR_RR_Group_two_F1641936_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-08_PANEL_2_LSR_DHS_Group_one_HB_F1641509_049|manual
	Classical monocytes (CD16- CD14+)|2017-05-08_PANEL_2_LSR_DHS_Group_one_HB_F1641509_049|manual
	Classical monocytes (CD16- CD14+)|2017-05-05_PANEL_2_LSR_RR_Group_two_F1641665_027|manual
	CD14-|2017-05-04_PANEL_2_LSR_RR_Group_one_F1641754_007|manual
	Classical monocytes (CD16- CD14+)|2017-05-04_PANEL_2_LSR_RR_Group_one_F1641754_007|manual
	CD45+|2017-05-05_PANEL_2_FORTESSA_ZF_group_one_F1641654_024|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-05-08_PANEL_2_LSR_DHS_Group_one_HB_F1640484_052|manual
	Classical monocytes (CD16- CD14+)|2017-05-08_PANEL_2_LSR_DHS_Group_two_F1641707_033|manual
	NK CD56LO|2017-05-04_PANEL_2_LSR_RR_Group_one_ZF_F1642034_035|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-05-05_PANEL_2_FORTESSA_ZF_group_one_F1641876_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-08_PANEL_2_LSR_DHS_Group_two_F1640762_029|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-05-05_PANEL_2_FORTESSA_ZF_group_one_F1641709_022|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_one_F1641650_004|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_one_F1641649_005|manual
	Classical monocytes (CD16- CD14+)|2017-05-04_PANEL_2_LSR_RR_Group_two_F1642004_027|manual
	CD14-|2017-05-04_PANEL_2_LSR_RR_Group_one_F1641923_002|manual
	Live immune cells (CD45+ PE-)|2017-05-05_PANEL_2_FORTESSA_ZF_group_one_RR_F1641647_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-04_PANEL_2_LSR_RR_Group_two_Ctl-G_001|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_one_ZF_F1641858_052|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-09_PANEL_2_LSR_DHS_Group_one_F1642941_009|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_one_ZF_F1641655_043|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-05-05_PANEL_2_FORTESSA_ZF_group_one_F1642006_023|manual
	NK CD56LO|2017-05-05_PANEL_2_FORTESSA_ZF_group_one_RR_F1634095_003|manual
	Classical monocytes (CD16- CD14+)|2017-05-05_PANEL_2_FORTESSA_ZF_group_one_RR_F1634095_003|manual
	Classical monocytes (CD16- CD14+)|2017-05-09_PANEL_2_LSR_DHS_Group_one_F1641676_001|manual
	Classical monocytes (CD16- CD14+)|2017-05-08_PANEL_2_LSR_DHS_Group_one_F1641504_013|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1638068_041|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1638068_041|manual
	Classical monocytes (CD16- CD14+)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1638068_041|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-05-12_PANEL_2_LSR_ZF_Group_one_F1632418_009|manual
	Classical monocytes (CD16- CD14+)|2017-05-13_PANEL_2_FORTESSA_ZF_group_two_F1640687_021|manual
	Classical monocytes (CD16- CD14+)|2017-05-15_PANEL_2_FORTESSA_DH_ZF_group_two_DHS_Ctl_E_027|manual
	Classical monocytes (CD16- CD14+)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641675_031|manual
	DC NK (CD20- CD14-)|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641915_035|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641888_036|manual
	NK CD56LO|2017-05-13_PANEL_2_LSR_ZF_Group_one_F1641966_003|manual
	DC NK (CD20- CD14-)|2017-05-13_PANEL_2_LSR_ZF_Group_one_F1641966_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641642_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-13_PANEL_2_LSR_ZF_Group_two_F1632453_019|manual
	Classical monocytes (CD16- CD14+)|2017-05-13_PANEL_2_LSR_ZF_Group_two_F1632453_019|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-12_PANEL_2_LSR_ZF_Group_two_F1641981_024|manual
	NK CD56LO|2017-05-15_PANEL_2_FORTESSA_DH_ZF_group_one_ZF_F1641871_023|manual
	CD14-|2017-05-15_PANEL_2_FORTESSA_DH_ZF_group_one_ZF_F1641871_023|manual
	Classical monocytes (CD16- CD14+)|2017-05-15_PANEL_2_FORTESSA_DH_ZF_group_one_ZF_F1641871_023|manual
	Classical monocytes (CD16- CD14+)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641988_033|manual
	Classical monocytes (CD16- CD14+)|2017-05-12_PANEL_2_LSR_ZF_Group_one_F1641967_008|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-05-12_PANEL_2_LSR_ZF_Group_one_F1641967_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-12_PANEL_2_LSR_ZF_Group_one_HB_F1641742_035|manual
	Classical monocytes (CD16- CD14+)|2017-05-12_PANEL_2_LSR_ZF_Group_one_HB_F1641742_035|manual
	CD45-|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641722_034|manual
	DC NK (CD20- CD14-)|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641722_034|manual
	Live immune cells (CD45+ PE-)|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641722_034|manual
	Classical monocytes (CD16- CD14+)|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641722_034|manual
	NK CD56LO|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641900_031|manual
	Classical monocytes (CD16- CD14+)|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641900_031|manual
	DC NK (CD20- CD14-)|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641645_039|manual
	Classical monocytes (CD16- CD14+)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641964_040|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-11_PANEL_2_LSR_ZF_Group_two_F1641749_027|manual
	DC NK (CD20- CD14-)|2017-05-11_PANEL_2_LSR_ZF_Group_one_F1641769_003|manual
	Classical monocytes (CD16- CD14+)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641730_037|manual
	Classical monocytes (CD16- CD14+)|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_one_DHS_F1641648_002|manual
	DC (HLA-DR+)|2017-05-11_PANEL_2_FORTESSA_HBpostboardreplacment_group_one_Ctl-F_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_one_DHS_F1632446_005|manual
	Classical monocytes (CD16- CD14+)|2017-05-09_PANEL_2_LSR_DHS_Group_one_ZF_F1642688_050|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-12_PANEL_2_FORTESSA_HB_group_one_HB_F1641908_027|manual
	CD14-|2017-05-12_PANEL_2_LSR_ZF_Group_one_F1641962_001|manual
	Classical monocytes (CD16- CD14+)|2017-05-12_PANEL_2_LSR_ZF_Group_one_F1641962_001|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641942_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-12_PANEL_2_LSR_ZF_Group_two_Ctl-H_031|manual
	NK CD56LO|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1640763_038|manual
	DC NK (CD20- CD14-)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641884_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-09_PANEL_2_LSR_DHS_Group_two_F1641919_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_one_ZF_F1634274_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-18_PANEL_2_FORTESSA_ZF_HB_group_two_HB_Ctl-E_040|manual
	Classical monocytes (CD16- CD14+)|2017-05-18_PANEL_2_FORTESSA_ZF_HB_group_two_HB_Ctl-E_040|manual
	Classical monocytes (CD16- CD14+)|2017-05-18_PANEL_2_FORTESSA_ZF_HB_group_one_HB_F1641788_029|manual
	Classical monocytes (CD16- CD14+)|2017-05-16_PANEL_2_LSR_DHS_Group_one_ZF_F1638409_032|manual
	NK CD56LO|2017-05-16_PANEL_2_LSR_DHS_Group_two_DHS_F1632704_024|manual
	Classical monocytes (CD16- CD14+)|2017-05-16_PANEL_2_LSR_DHS_Group_two_DHS_F1632704_024|manual
	NK CD56LO|2017-05-18_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1640415_007|manual
	NK CD56LO|2017-05-17_PANEL_2_LSR_ZF_Group_one_F1641747_010|manual
	NK CD56LO|2017-05-17_PANEL_2_LSR_ZF_Group_two_F1635157_030|manual
	Classical monocytes (CD16- CD14+)|2017-05-17_PANEL_2_LSR_ZF_Group_two_F1635157_030|manual
	NK CD56LO|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_two_DHS_F1638080_036|manual
	CD14-|2017-05-16_PANEL_2_FORTESSA_DHS_group_one_ZF_F1641927_028|manual
	Classical monocytes (CD16- CD14+)|2017-05-16_PANEL_2_FORTESSA_DHS_group_one_ZF_F1641927_028|manual
	Classical monocytes (CD16- CD14+)|2017-05-17_PANEL_2_LSR_ZF_Group_one_F1635160_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-16_PANEL_2_FORTESSA_DHS_group_one_DHS_F1632694_007|manual
	Classical monocytes (CD16- CD14+)|2017-05-16_PANEL_2_LSR_DHS_Group_two_ZF_F1632466_037|manual
	CD14-|2017-05-16_PANEL_2_FORTESSA_DHS_group_one_ZF_F1641894_029|manual
	DC NK (CD20- CD14-)|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_two_ZF_F1632444_022|manual
	Classical monocytes (CD16- CD14+)|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_two_ZF_F1632444_022|manual
	Classical monocytes (CD16- CD14+)|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_two_DHS_F1641954_040|manual
	Classical monocytes (CD16- CD14+)|2017-05-16_PANEL_2_LSR_DHS_Group_two_ZF_F1635153_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-17_PANEL_2_LSR_ZF_Group_one_F1635317_001|manual
	Classical monocytes (CD16- CD14+)|2017-05-17_PANEL_2_LSR_ZF_Group_one_F1635317_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-16_PANEL_2_LSR_DHS_Group_one_ZF_F1632445_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-16_PANEL_2_FORTESSA_DHS_group_one_DHS_F1642715_005|manual
	Classical monocytes (CD16- CD14+)|2017-05-16_PANEL_2_LSR_DHS_Group_one_DHS_F1641735_007|manual
	NK CD56LO|2017-05-18_PANEL_2_LSR_ZF_HB_Group_one_ZF_F1635697_005|manual
	Classical monocytes (CD16- CD14+)|2017-05-18_PANEL_2_LSR_ZF_HB_Group_one_ZF_F1635697_005|manual
	NK CD56LO|2017-05-15_PANEL_2_LSR_ZF,2f,DHS_Group_two_DHS_F1635326_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-17_PANEL_2_FORTESSA_ZF-postUVlaseralignement_speedadjust_group_two_ZF_F1632476_020|manual
	Classical monocytes (CD16- CD14+)|2017-05-23_PANEL_2_LSR_ZF_Group_two_DHS_F1642021_025|manual
	Classical monocytes (CD16- CD14+)|2017-05-23_PANEL_2_LSR_ZF_Group_two_DHS_F1635062_020|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-05-19_PANEL_2_LSR_ZF_HB_Group_two_HB_F1635059_034|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1634924_003|manual
	Classical monocytes (CD16- CD14+)|2017-05-23_PANEL_2_LSR_ZF_Group_one_DHS_F1635083_006|manual
	Classical monocytes (CD16- CD14+)|2017-05-18_PANEL_2_LSR_ZF_HB_Group_two_ZF_F1638133_025|manual
	NK CD56LO|2017-05-19_PANEL_2_LSR_ZF_HB_Group_one_ZF_F1638117_007|manual
	DC NK (CD20- CD14-)|2017-05-19_PANEL_2_LSR_ZF_HB_Group_two_ZF_F1632431_022|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1635061_006|manual
	NK CD56LO|2017-05-23_PANEL_2_FORTESSA_DHS_ZF_group_one_ZF_F1632465_029|manual
	Classical monocytes (CD16- CD14+)|2017-05-19_PANEL_2_LSR_ZF_HB_Group_two_ZF_F1635402_023|manual
	NK CD56LO|2017-05-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1635042_014|manual
	DC (HLA-DR+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1635042_014|manual
	CD45+|2017-05-18_PANEL_2_LSR_ZF_HB_Group_two_HB_F1641723_035|manual
	NK CD56LO|2017-05-18_PANEL_2_LSR_ZF_HB_Group_two_HB_F1641723_035|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1632673_013|manual
	NK CD56LO|2017-05-19_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1635029_026|manual
	Classical monocytes (CD16- CD14+)|2017-05-19_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1635029_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-23_PANEL_2_FORTESSA_DHS_ZF_group_two_DHS_F1641440_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-19_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1635152_001|manual
	Classical monocytes (CD16- CD14+)|2017-05-23_PANEL_2_FORTESSA_DHS_ZF_group_one_ZF_F1641416_033|manual
	Classical monocytes (CD16- CD14+)|2017-05-23_PANEL_2_FORTESSA_DHS_ZF_group_one_DHS_F1635365_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-19_PANEL_2_LSR_ZF_HB_Group_two_ZF_Ctl_E_028|manual
	Classical monocytes (CD16- CD14+)|2017-05-25_PANEL_2_FORTESSA_ZF_group_one_F1635170_008|manual
	Classical monocytes (CD16- CD14+)|2017-05-31_PANEL_2_FORTESSA_DHS_ZF_group_two_DHS_F1641434_024|manual
	NK CD56LO|2017-05-26_PANEL_2_FORTESSA_ZF_group_one_HB_F1635027_029|manual
	Classical monocytes (CD16- CD14+)|2017-05-25_PANEL_2_FORTESSA_ZF_group_two_F1635032_038|manual
	Classical monocytes (CD16- CD14+)|2017-05-25_PANEL_2_FORTESSA_ZF_group_one_F1641793_007|manual
	CD14-|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1632676_038|manual
	Classical monocytes (CD16- CD14+)|2017-05-31_PANEL_2_FORTESSA_DHS_ZF_group_two_ZF_F1641809_038|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1638113_005|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1632678_027|manual
	NK CD56LO|2017-05-31_PANEL_2_LSR_DHS_ZF_Group_one_DHS_F1635174_002|manual
	Classical monocytes (CD16- CD14+)|2017-05-31_PANEL_2_LSR_DHS_ZF_Group_one_DHS_F1635174_002|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1638374_011|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1635212_040|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1632666_034|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1638129_029|manual
	Classical monocytes (CD16- CD14+)|2017-05-30_PANEL_2_FORTESSA_DHS_group_two_F1638160_034|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1635379_037|manual
	CD45+|2017-05-31_PANEL_2_FORTESSA_DHS_ZF_group_two_ZF_F1641452_042|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-25_PANEL_2_FORTESSA_ZF_group_two_F1638381_034|manual
	Classical monocytes (CD16- CD14+)|2017-05-25_PANEL_2_FORTESSA_ZF_group_one_F1641971_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-31_PANEL_2_FORTESSA_DHS_ZF_group_two_DHS_F1640860_023|manual
	Classical monocytes (CD16- CD14+)|2017-05-31_PANEL_2_FORTESSA_DHS_ZF_group_two_DHS_F1640860_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_Ctl_H_042|manual
	Classical monocytes (CD16- CD14+)|2017-05-25_PANEL_2_FORTESSA_ZF_group_one_F1635072_012|manual
	Classical monocytes (CD16- CD14+)|2017-05-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1635273_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-25_PANEL_2_FORTESSA_ZF_group_two_F1638140_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-05-30_PANEL_2_LSR-HB-postbaseline_Group_one_DHS_Ctl-H_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two-HB_F1634948_020|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two_ZF_F1635132_040|Manual
	NK CD56LO|2017-06-05_PANEL_2_LSR_DHS_Group_one_F1635286_003|Manual
	Classical monocytes (CD16- CD14+)|2017-06-05_PANEL_2_LSR_DHS_Group_one_F1635286_003|Manual
	NK CD56LO|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two-HB_F1641827_027|Manual
	CD14-|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two-HB_F1641827_027|Manual
	CD14-|2017-06-01_PANEL_2_LSR_HB_ZF_Group_one-ZF_F1634937_033|Good
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_one-ZF_F1634937_033|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-HB_F1634925_023|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two_ZF_F1635121_037|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_FORTESSA_HB_group_one_HB_F1641448_008|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_FORTESSA_HB_group_one_HB_F1635167_001|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-ZF_F1634989_042|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-02_PANEL_2_FORTESSA_HB_group_two_ZF_F1641454_043|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_one-ZF_F1641831_029|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-ZF_F1641458_039|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-ZF_F1638154_037|Manual
	NK CD56LO|2017-06-02_PANEL_2_FORTESSA_HB_group_two_HB_F1635239_022|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-HB_F1641449_027|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-02_PANEL_2_LSR_HB_Group_two-ZF_F1635290_036|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-ZF_F1638147_036|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_FORTESSA_HB_group_one_HB_F1641422_003|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-02_PANEL_2_LSR_HB_Group_two-HB_F1635310_023|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two_ZF_F1635408_042|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-ZF_F1641791_040|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_FORTESSA_HB_group_two_HB_F1635396_026|Manual
	NK CD56LO|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-ZF_F1635389_038|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_two-ZF_F1635389_038|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two_ZF_F1638161_038|Manual
	CD14-|2017-06-02_PANEL_2_FORTESSA_HB_group_one_HB_F1635084_006|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_FORTESSA_HB_group_one_HB_F1635084_006|Manual
	DC NK (CD20- CD14-)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two-HB_F1635164_024|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_LSR_HB_Group_one-HB_F1635207_005|Manual
	NK CD56LO|2017-06-02_PANEL_2_LSR_HB_Group_one-ZF_F1635259_033|Manual
	NK CD56LO|2017-06-02_PANEL_2_FORTESSA_HB_group_two_HB_F1641423_025|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_FORTESSA_HB_group_one_HB_F1641824_007|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_LSR_HB_ZF_Group_one-ZF_F1641432_035|Manual
	NK CD56LO|2017-06-05_PANEL_2_FORTESSSA_DHS_group_two_ZF_F1635244_045|Manual
	Classical monocytes (CD16- CD14+)|2017-06-02_PANEL_2_FORTESSA_HB_group_one_HB_F1635199_002|Manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two_ZF_F1641661_039|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_two-HB_F1638073_026|Manual
	NK CD56LO|2017-06-02_PANEL_2_FORTESSA_HB_group_two_HB_F1635171_027|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-21_PANEL_2_DHS_Group_two_F1636809_026|manual
	Classical monocytes (CD16- CD14+)|2016-06-21_PANEL_2_DHS_Group_one_F1636782_012|manual
	Classical monocytes (CD16- CD14+)|2016-07-06_PANEL_2_ZF_Group_one_F1632325_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-23_PANEL_2_ZF_Group_two_F1632333_028|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-23_PANEL_2_ZF_Group_two_F1632333_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_one_F1636468_002|manual
	DC (HLA-DR+)|2016-06-22_PANEL_2_ZF_Group_one_F1636468_002|manual
	Live immune cells (CD45+ PE-)|2016-06-21_PANEL_2_DHS_Group_two_F1636848_030|manual
	CD14-|2016-06-22_PANEL_2_ZF_Group_two_F1631281_026|manual
	Classical monocytes (CD16- CD14+)|2016-06-28_PANEL_2_DHS_Group_one_F1631188_001|abnormal
	DC NK MONOCYTES (CD3- CD19-)|2016-06-22_PANEL_2_ZF_Group_two_F1632055_029|manual
	Classical monocytes (CD16- CD14+)|2016-06-28_PANEL_2_DHS_Group_one_F1632051_010|abnormal
	NK CD56LO|2016-06-22_PANEL_2_ZF_Group_two_F1632304_024|manual
	Classical monocytes (CD16- CD14+)|2016-06-27_PANEL_2_DHS_Group_one_F1632061_011|manual
	Classical monocytes (CD16- CD14+)|2016-06-27_PANEL_2_DHS_Group_one_F1632039_013|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-24_PANEL_2_ZF_Group_one_F1632322_007|manual
	Classical monocytes (CD16- CD14+)|2016-06-27_PANEL_2_DHS_Group_one_F1631341_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_two_Ctl-D_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-07_PANEL_2_ZF_Group_one_F1632359_006|manual
	NK CD56LO|2016-06-27_PANEL_2_DHS_Group_two_F1632042_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_one_F1649317_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-22_PANEL_2_ZF_Group_two_F1632317_030|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-06-22_PANEL_2_ZF_Group_two_F1632317_030|manual
	CD14-|2016-06-22_PANEL_2_ZF_Group_one_F1632316_008|manual
	Classical monocytes (CD16- CD14+)|2016-06-22_PANEL_2_ZF_Group_one_F1631021_009|manual
	NK CD56LO|2016-06-27_PANEL_2_DHS_Group_two_F1632320_031|manual
	Classical monocytes (CD16- CD14+)|2016-06-21_PANEL_2_DHS_Group_one_F1636795_008|manual
	NK CD56LO|2016-06-22_PANEL_2_ZF_Group_one_F1631015_010|manual
	Classical monocytes (CD16- CD14+)|2016-06-22_PANEL_2_ZF_Group_two_F1632046_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-20_PANEL_2_DHS_Group_two_Ctl-A_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-06-23_PANEL_2_ZF_Group_one_F1632309_001|manual
	Classical monocytes (CD16- CD14+)|2017-06-07_PANEL_2_FORTESSA_ZF_RR_group_one_RR_F1638351_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-05_PANEL_2_LSR_DHS_Group_one_ZF_F1635301_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-06_PANEL_2_LSR_DHS_Group_one_F1635102_007|manual
	NK CD56LO|2017-06-05_PANEL_2_LSR_DHS_Group_two_002_F1635346_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-07_PANEL_2_LSR_ZF_RR_Group_two_RR_F1635340_035|manual
	Classical monocytes (CD16- CD14+)|2017-05-31_PANEL_2_LSR_DHS_ZF_Group_two_ZF_F1634972_038|manual
	NK CD56LO|2017-06-07_PANEL_2_LSR_ZF_RR_Group_one_RR_F1634971_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-07_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1638353_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-07_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1635223_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-07_PANEL_2_FORTESSA_ZF_RR_group_one_RR_F1633220_033|manual
	Classical monocytes (CD16- CD14+)|2017-05-31_PANEL_2_LSR_DHS_ZF_Group_two_ZF_F1634959_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-07_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1638348_003|manual
	NK CD56LO|2017-05-31_PANEL_2_LSR_DHS_ZF_Group_two_ZF_F1635116_041|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-07_PANEL_2_FORTESSA_ZF_RR_group_two_ZF_F1638350_023|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-06-07_PANEL_2_LSR_ZF_RR_Group_two_RR_F1635376_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-07_PANEL_2_LSR_ZF_RR_Group_two_RR_Ctl-E_039|manual
	Classical monocytes (CD16- CD14+)|2017-06-01_PANEL_2_FORTESSA_HB_ZF_group_one_ZF_F1635366_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-05_PANEL_2_LSR_DHS_Group_one_ZF_F1638139_027|manual
	CD45+|2017-05-31_PANEL_2_LSR_DHS_ZF_Group_two_DHS_Ctl-G_027|manual
	Classical monocytes (CD16- CD14+)|2017-06-05_PANEL_2_LSR_DHS_Group_two_F1635069_020|manual
	CD45+|2017-05-31_PANEL_2_LSR_DHS_ZF_Group_two_DHS_Ctl-G_001|manual
	NK CD56LO|2017-06-07_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1635096_005|manual
	NK CD56LO|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1641834_002|manual
	NK CD56LO|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_two_ZF_F1635264_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_one_EC_PBMC-A2_043|manual
	NK CD56LO|2017-06-09_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1632850_005|manual
	NK CD56LO|2017-06-08_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1638094_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-08_PANEL_2_LSR_ZF_RR_Group_two_RR_F1633196_041|manual
	NK CD56LO|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_one_DHS_F1632584_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-08_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1632580_043|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-08_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1635272_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_two_001_F1637731_035|manual
	Classical monocytes (CD16- CD14+)|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_two_001_F1633408_040|manual
	Classical monocytes (CD16- CD14+)|2017-06-08_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1638339_037|manual
	NK CD56LO|2017-06-08_PANEL_2_LSR_ZF_RR_Group_two_RR_F1633188_038|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_two_DHS_F1632515_027|manual
	Classical monocytes (CD16- CD14+)|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_two_DHS_F1632515_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-09_PANEL_2_LSR_ZF_RR_Group_one_RR_F1632771_034|manual
	NK CD56LO|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1633201_005|manual
	NK CD56LO|2017-06-08_PANEL_2_LSR_ZF_RR_Group_one_RR_F1635020_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-08_PANEL_2_FORTESSA_ZF_RR_group_two_ZF_F1633221_023|manual
	NK CD56LO|2017-06-08_PANEL_2_LSR_ZF_RR_Group_one_RR_F1635292_033|manual
	NK CD56LO|2017-06-09_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1632536_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_two_DHS_F1633120_021|manual
	NK CD56LO|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1638087_007|manual
	Classical monocytes (CD16- CD14+)|2017-06-09_PANEL_2_LSR_ZF_RR_Group_one_RR_F1632522_036|manual
	NK CD56LO|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1652634_038|manual
	DC (HLA-DR+)|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1638125_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-09_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1632855_022|manual
	NK CD56LO|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_two_ZF_F1632842_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-08_PANEL_2_LSR_ZF_RR_Group_two_RR_F1638143_039|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-06-12_PANEL_2_FORTESSA_DHS_ZF_group_two_001_F1637669_039|manual
	DC (HLA-DR+)|2017-06-09_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1635071_042|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-09_PANEL_2_LSR_ZF_RR_Group_two_RR_F1633369_037|manual
	NK CD56LO|2017-06-09_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1632839_006|manual
	NK CD56LO|2017-06-08_PANEL_2_LSR_ZF_RR_Group_two_RR_F1635025_037|manual
	NK CD56LO|2017-06-08_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1638358_020|manual
	CD14-|2017-06-13_PANEL_2_FORTESSA_DHS_group_one_DHS_F1641666_003|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-14_PANEL_2_LSR_ZF_RR_Group_one_RR_F1633261_031|Manual
	Classical monocytes (CD16- CD14+)|2017-06-14_PANEL_2_LSR_ZF_RR_Group_one_RR_F1633261_031|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-06-12_PANEL_2_LSR_DHS_ZF_Group_two_ZF_F1635309_037|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-12_PANEL_2_LSR_DHS_ZF_Group_one_ZF_F1633114_033|Manual
	NK CD56LO|2017-06-12_PANEL_2_LSR_DHS_ZF_Group_one_ZF_F1633398_030|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-14_PANEL_2_FORTESSA_ZF_RR_group_one_RR_F1637664_029|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-14_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1633157_021|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-15_PANEL_2_FORTESSA_ZF_group_one_ZF_F1632743_003|Manual
	Classical monocytes (CD16- CD14+)|2017-06-15_PANEL_2_FORTESSA_ZF_group_one_ZF_F1632743_003|Manual
	Classical monocytes (CD16- CD14+)|2017-06-13_PANEL_2_LSR_DHS_Group_two_DHS_F1637718_024|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-14_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1637721_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-13_PANEL_2_LSR_DHS_Group_two_RR_F1632579_042|Manual
	Classical monocytes (CD16- CD14+)|2017-06-13_PANEL_2_LSR_DHS_Group_one_DHS_F1632861_008|Manual
	NK CD56LO|2017-06-13_PANEL_2_LSR_DHS_Group_one_DHS_F1637705_002|Manual
	Classical monocytes (CD16- CD14+)|2017-06-14_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1632753_022|Manual
	Classical monocytes (CD16- CD14+)|2017-06-13_PANEL_2_LSR_DHS_Group_one_DHS_F1633125_006|Manual
	NK CD56LO|2017-06-13_PANEL_2_LSR_DHS_Group_one_RR_F1637716_029|Manual
	DC NK (CD20- CD14-)|2017-06-14_PANEL_2_FORTESSA_ZF_RR_group_two_ZF_F1633142_025|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-14_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1633386_003|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-13_PANEL_2_LSR_DHS_Group_two_RR_F1633395_040|Manual
	CD45+|2017-06-13_PANEL_2_LSR_DHS_Group_one_RR_F1633116_032|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-13_PANEL_2_FORTESSA_DHS_group_one_RR_F1637728_031|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-14_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1633131_005|Manual
	CD14-|2017-06-19_PANEL_2_FORTESSA_DHS_group_two_ZF_F1633350_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-16_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1633042_028|manual
	Classical monocytes (CD16- CD14+)|2017-06-19_PANEL_2_FORTESSA_DHS_group_two_DHS_F1642737_025|manual
	CD45+|2017-06-19_PANEL_2_LSR_DHS_Group_one_ZF_F1632696_032|manual
	Classical monocytes (CD16- CD14+)|2017-06-19_PANEL_2_LSR_DHS_Group_one_ZF_F1632696_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-16_PANEL_2_LSR_ZF_RR_Group_two_RR_F1633308_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-15_PANEL_2_LSR_ZF_Group_one_EC_Ctl-F_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-15_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637678_004|manual
	Classical monocytes (CD16- CD14+)|2017-06-15_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637678_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-16_PANEL_2_FORTESSA_ZF_group_two_ZF_F1632810_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-16_PANEL_2_FORTESSA_ZF_group_one_ZF_F1633388_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-16_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637674_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-16_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1633002_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-19_PANEL_2_LSR_DHS_Group_one_ZF_F1632953_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-16_PANEL_2_LSR_ZF_RR_Group_two_RR_F1633352_043|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-21_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1633237_022|manual
	NK CD56LO|2017-06-21_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1633376_007|manual
	Classical monocytes (CD16- CD14+)|2017-06-19_PANEL_2_LSR_DHS_Group_two_ZF_F1633367_036|manual
	Classical monocytes (CD16- CD14+)|2017-06-21_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1632607_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-21_PANEL_2_LSR_ZF_RR_Group_one_RR_F1632732_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-20_PANEL_2_LSR_DHS_Group_one_DHS_F1632984_005|manual
	Classical monocytes (CD16- CD14+)|2017-06-21_PANEL_2_FORTESSA_ZF_RR_group_one_RR_F1632609_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-21_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1632829_023|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-06-21_PANEL_2_LSR_ZF_RR_Group_two_RR_F1632790_037|manual
	NK CD56LO|2017-06-21_PANEL_2_LSR_ZF_RR_Group_two_RR_F1632808_039|manual
	Classical monocytes (CD16- CD14+)|2017-06-21_PANEL_2_FORTESSA_ZF_RR_group_one_RR_F1632764_029|manual
	DC NK (CD20- CD14-)|2017-06-23_PANEL_2_LSR_ZF_Group_one_ZF_F1632958_004|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-06-23_PANEL_2_LSR_ZF_Group_one_ZF_F1632958_004|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-29_PANEL_2_LSR_ZF_HB_Group_one_ZF_F1642651_004|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-30_PANEL_2_LSR_ZF_Group_one_ZF_F1632595_002|Manual
	CD14-|2017-07-05_PANEL_2_FORTESSA_DHS_group_one_DHS_F1637745_002|Manual
	Classical monocytes (CD16- CD14+)|2017-07-05_PANEL_2_FORTESSA_DHS_group_one_DHS_F1637745_002|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-27_PANEL_2_LSR_DHS_Group_two_RR_Ctl-E_1_024|Manual
	Classical monocytes (CD16- CD14+)|2017-06-27_PANEL_2_LSR_DHS_Group_two_RR_Ctl-E_1_024|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-28_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1633099_005|Manual
	Classical monocytes (CD16- CD14+)|2017-06-29_PANEL_2_LSR_ZF_HB_Group_one_ZF_F1632509_001|Manual
	CD14-|2017-06-30_PANEL_2_FORTESSA_ZF_group_one_ZF_F1633328_001|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-06-30_PANEL_2_FORTESSA_ZF_group_one_ZF_F1633328_001|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-05_PANEL_2_FORTESSA_DHS_group_one_EC_Ctl-E_034|Manual
	Classical monocytes (CD16- CD14+)|2017-07-05_PANEL_2_FORTESSA_DHS_group_one_EC_Ctl-E_034|Manual
	DC (HLA-DR+)|2017-06-30_PANEL_2_LSR_ZF_Group_one_ZF_F1635004_004|Manual
	NK CD56LO|2017-06-28_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1633231_019|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-29_PANEL_2_FORTESSA_ZF_HB_group_one_HB_Ctl-E_029|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-28_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1638363_002|Manual
	Classical monocytes (CD16- CD14+)|2017-06-27_PANEL_2_LSR_DHS_Group_two_RR_Ctl-E_2_025|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-26_PANEL_2_LSR_DHS_Group_one_F1632588_008|Manual
	CD14-|2017-06-29_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1633293_006|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-29_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1632749_001|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-06-26_PANEL_2_LSR_DHS_Group_two_F1632508_029|Manual
	CD14-|2017-06-29_PANEL_2_LSR_ZF_HB_Group_two_ZF_F1632834_022|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1632774_020|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1637485_002|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_F1632736_022|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-05_PANEL_2_FORTESSA_DHS_group_one_RR_F1633030_023|manual
	NK CD56LO|2017-07-11_PANEL_2_FORTESSA_ZF_group_one_ZF_F1639990_003|manual
	Classical monocytes (CD16- CD14+)|2017-07-05_PANEL_2_LSR_DHS_Group_two_RR_F1637808_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-07_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1633021_002|manual
	CD14-|2017-07-07_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1640060_027|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1637500_023|manual
	CD14-|2017-07-10_PANEL_2_LSR_ZF_HB_Group_two_ZF_F1637567_019|manual
	Classical monocytes (CD16- CD14+)|2017-07-10_PANEL_2_LSR_ZF_HB_Group_two_ZF_F1637567_019|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1633018_021|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_F1633164_020|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1637708_022|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1637502_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1637761_003|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_one_F1633102_003|manual
	NK CD56LO|2017-07-05_PANEL_2_LSR_DHS_Group_two_DHS_F1637491_019|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-07_PANEL_2_LSR_ZF_Group_one_ZF_F1632737_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1637746_019|manual
	CD14-|2017-07-07_PANEL_2_FORTESSA_ZF_RR_group_two_RR_F1637478_029|manual
	Classical monocytes (CD16- CD14+)|2017-07-07_PANEL_2_FORTESSA_ZF_RR_group_one_ZF_F1637759_005|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_F1637747_018|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_one_F1637801_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-10_PANEL_2_LSR_ZF_HB_Group_one_ZF_F1633090_005|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_two_ZF_F1637756_018|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-10_PANEL_2_LSR_ZF_HB_Group_one_HB_F1637800_023|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_one_F1640033_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_Ctl-H_023|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_Ctl-H_023|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_F1640037_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_F1637754_019|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_two_F1637754_019|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1637475_005|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_FORTESSA_ZF_HB_group_one_ZF_F1632489_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-10_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637474_005|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_one_F1637510_002|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-06_PANEL_2_LSR_ZF_HB_Group_one_F1637836_005|manual
	NK CD56LO|2017-07-14_PANEL_2_FORTESSA_HB_group_two_ZF_F1640277_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_4M_A_018|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_2M_A_020|manual
	NK CD56LO|2017-07-17_PANEL_2_LSR_DHS_Group_one_DHS_Ctl-E_011|manual
	CD14-|2017-07-17_PANEL_2_LSR_DHS_Group_one_DHS_Ctl-E_011|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_two_HB_F1640233_020|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_two_HB_F1640242_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_4M_B_019|manual
	Classical monocytes (CD16- CD14+)|2017-07-11_PANEL_2_LSR_ZF_RR_Group_one_ZF_F1637815_001|manual
	CD14-|2017-07-17_PANEL_2_LSR_DHS_Group_one_DHS_F1640221_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_1M_A_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-19_PANEL_2_LSR_RR_Group_one_EC_Ctl-E_015|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_one_HB_F1640259_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_250K_B_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-11_PANEL_2_LSR_ZF_RR_Group_two_ZF_F1640043_019|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-14_PANEL_2_LSR_HB_Group_one_ZF_F1640248_025|manual
	NK CD56LO|2017-07-11_PANEL_2_LSR_ZF_RR_Group_two_RR_F1637583_032|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_two_HB_F1637481_021|manual
	CD14-|2017-07-17_PANEL_2_LSR_DHS_Group_one_DHS_F1640165_007|manual
	NK CD56LO|2017-07-19_PANEL_2_FORTESSA_RR_group_two_RR_F1639948_022|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_one_HB_F1640209_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_one_HB_F1640239_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-19_PANEL_2_FORTESSA_RR_group_two_RR_F1641476_021|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_two_HB_F1640240_019|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_one_HB_F1640207_003|manual
	CD14-|2017-07-17_PANEL_2_LSR_DHS_Group_one_DHS_F1640250_006|manual
	Classical monocytes (CD16- CD14+)|2017-07-17_PANEL_2_LSR_DHS_Group_one_DHS_F1640250_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-19_PANEL_2_FORTESSA_RR_group_two_RR_F1640174_023|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-12_PANEL_2_LSR_ZF_Group_one_RR_F1637810_005|manual
	CD14-|2017-07-17_PANEL_2_LSR_DHS_Group_one_DHS_F1637837_009|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-11_PANEL_2_LSR_ZF_RR_Group_two_RR_F1640024_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-11_PANEL_2_LSR_ZF_RR_Group_two_RR_F1640061_031|manual
	Classical monocytes (CD16- CD14+)|2017-07-19_PANEL_2_FORTESSA_RR_group_one_RR_F1640254_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_1M_B_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_LSR_ZF_Group_one_RR_F1633317_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_two_HB_F1640216_018|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_2M_B_021|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-12_PANEL_2_FORTESSA_ZF_group_one_ZF_2M_B_021|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-14_PANEL_2_FORTESSA_HB_group_one_HB_F1641426_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-21_PANEL_2_LSR_RR_Group_two_HB_F1637684_025|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-24_PANEL_2_LSR_DHS_Group_one_ZF_F1637883_023|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-20_PANEL_2_LSR_ZF_HB_Group_one_HB_F1639946_027|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-24_PANEL_2_FORTESSA_DHS_group_two_ZF_F1637906_031|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1637652_006|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-21_PANEL_2_LSR_RR_Group_two_RR_F1637616_022|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-24_PANEL_2_LSR_DHS_Group_two_DHS_Ctl-G_021|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-21_PANEL_2_LSR_RR_Group_two_HB_F1637631_026|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-24_PANEL_2_FORTESSA_DHS_group_two_DHS_F1637531_023|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-25_PANEL_2_LSR_DHS_Group_one_RR_F1637821_025|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-20_PANEL_2_LSR_ZF_HB_Group_two_HB_Ctl-E_032|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-25_PANEL_2_FORTESSA_DHS_group_two_DHS_F1637864_021|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-21_PANEL_2_FORTESSA_RR_group_two_RR_F1637650_021|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-21_PANEL_2_FORTESSA_RR_group_two_RR_F1637903_018|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-24_PANEL_2_FORTESSA_DHS_group_one_DHS_F1640195_003|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-25_PANEL_2_FORTESSA_DHS_group_two_DHS_F1640274_019|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-21_PANEL_2_FORTESSA_RR_group_two_RR_F1635330_019|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-21_PANEL_2_FORTESSA_RR_group_two_RR_F1637869_022|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-24_PANEL_2_LSR_DHS_Group_two_ZF_F1633404_028|Manual
	Classical monocytes (CD16- CD14+)|2017-07-21_PANEL_2_LSR_RR_Group_one_RR_F1639942_005|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-21_PANEL_2_FORTESSA_RR_group_two_RR_F1637871_020|Manual
	CD14-|2017-07-21_PANEL_2_LSR_RR_Group_two_EC_F1637620_029|Manual
	Classical monocytes (CD16- CD14+)|2017-07-21_PANEL_2_FORTESSA_RR_group_two_EC_F1637627_028|Manual
	CD14-|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1640219_023|manual
	HLA-DR+|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637862_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637862_030|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637862_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637796_031|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1637538_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-27_PANEL_2_FORTESSA_ZF_group_two_HB_Ctl-E_038|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_two_ZF_F1632602_022|manual
	CD14-|2017-07-28_PANEL_2_FORTESSA_HB_group_oneB_HB_F1632624_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_ZF_F1632902_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-26_PANEL_2_LSR_ZF_Group_one_ZF_F1637661_005|manual
	CD14-|2017-07-28_PANEL_2_FORTESSA_HB_group_oneB_HB_F1637416_036|manual
	CD14-|2017-07-28_PANEL_2_FORTESSA_HB_group_three_HB_F1633333_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-25_PANEL_2_LSR_DHS_Group_two_RR_F1639931_030|manual
	CD14-|2017-07-28_PANEL_2_LSR_HB_Group_one_EC_Ctl-H_033|manual
	Classical monocytes (CD16- CD14+)|2017-07-28_PANEL_2_LSR_HB_Group_one_EC_Ctl-H_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-26_PANEL_2_LSR_ZF_Group_one_RR_F1637782_025|manual
	CD14-|2017-07-28_PANEL_2_LSR_HB_Group_one_EC_F1632803_031|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637702_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1637639_026|manual
	CD14-|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_ZF_F1632658_001|manual
	DC (HLA-DR+)|2017-07-26_PANEL_2_FORTESSA_ZF_group_three_RR_F1637715_023|manual
	CD14-|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1637554_028|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1637554_028|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_FORTESSA_ZF_group_four_RR_F1637560_029|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_two_ZF_F1637856_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_HB_F1637516_031|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_two_ZF_F1633075_022|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-28_PANEL_2_LSR_HB_Group_one_HB_F1637866_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-28_PANEL_2_FORTESSA_HB_group_three_HB_F1637765_024|manual
	CD14-|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637463_005|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637463_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-28_PANEL_2_FORTESSA_HB_group_one_HB_F1632654_001|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-28_PANEL_2_FORTESSA_HB_group_one_HB_F1632654_001|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_two_ZF_F1637545_018|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-27_PANEL_2_LSR_ZF_Group_one_ZF_F1632661_002|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_two_ZF_F1640236_019|manual
	CD14-|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_Ctl-H_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_Ctl-H_030|manual
	CD14-|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_HB_F1632901_032|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_EC_F1637464_023|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-28_PANEL_2_FORTESSA_HB_group_one_EC_F1632626_029|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-28_PANEL_2_FORTESSA_HB_group_two_HB_F1636595_019|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_FORTESSA_ZF_group_four_RR_Ctl-F_033|manual
	Live immune cells (CD45+ PE-)|2017-07-26_PANEL_2_LSR_ZF_Group_one_EC_F1637775_022|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1637593_025|manual
	NK CD56LO|2017-07-26_PANEL_2_LSR_ZF_Group_one_ZF_F1640176_003|manual
	CD14-|2017-07-26_PANEL_2_FORTESSA_ZF_group_four_RR_F1637542_030|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_FORTESSA_ZF_group_four_RR_F1637542_030|manual
	CD14-|2017-07-28_PANEL_2_FORTESSA_HB_group_three_HB_F1637540_026|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-25_PANEL_2_LSR_DHS_Group_three_RR_F1637874_035|manual
	CD14-|2017-07-25_PANEL_2_LSR_DHS_Group_two_RR_F1637902_031|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_EC_F1637454_024|manual
	CD14-|2017-07-28_PANEL_2_FORTESSA_HB_group_oneB_HB_F1632903_033|manual
	CD14-|2017-07-27_PANEL_2_LSR_ZF_Group_one_ZF_F1637850_001|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_one_EC_F1637549_025|manual
	Live immune cells (CD45+ PE-)|2017-07-26_PANEL_2_LSR_ZF_Group_one_EC_F1637596_020|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637562_032|manual
	DC (HLA-DR+)|2017-07-26_PANEL_2_FORTESSA_ZF_group_one_ZF_F1635117_005|manual
	CD14-|2017-07-27_PANEL_2_LSR_ZF_Group_two_ZF_F1637900_020|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-27_PANEL_2_LSR_ZF_Group_two_ZF_F1637900_020|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_FORTESSA_ZF_group_two_ZF_F1637648_020|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637548_029|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1637898_024|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-28_PANEL_2_FORTESSA_HB_group_one_EC_F1632648_028|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_FORTESSA_ZF_group_four_RR_F1637768_031|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_two_ZF_F1637557_019|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_FORTESSA_ZF_group_four_RR_F1637860_032|manual
	NK CD56LO|2017-07-26_PANEL_2_FORTESSA_ZF_group_two_EC_F1637786_021|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_FORTESSA_ZF_group_four_RR_F1637547_028|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-27_PANEL_2_LSR_ZF_Group_one_EC_F1637553_029|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637784_033|manual
	DC (HLA-DR+)|2017-07-26_PANEL_2_FORTESSA_ZF_group_three_RR_F1637771_025|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637769_028|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-07-26_PANEL_2_LSR_ZF_Group_two_RR_F1637769_028|manual
	NK CD56LO|2016-07-08_PANEL_2_ZF_Group_two_F1632054_031|manual
	Classical monocytes (CD16- CD14+)|2016-07-08_PANEL_2_ZF_Group_two_F1632054_031|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1631196_024|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632139_030|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-13_PANEL_2_ZF_Group_one_F1632139_030|manual
	NK CD56LO|2016-07-12_PANEL_2_DHS_Group_two_F1631205_031|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-07-12_PANEL_2_DHS_Group_two_F1631205_031|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-14_PANEL_2_ZF_Group_one_F1631229_007|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-07_PANEL_2_ZF_Group_two_F1632105_025|manual
	NK CD56LO|2016-07-11_PANEL_2_DHS_Group_one_F1632404_005|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632159_027|manual
	Live immune cells (CD45+ PE-)|2016-07-11_PANEL_2_DHS_Group_one_F1632121_008|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_Ctl-B_010|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632156_025|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1632080_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-13_PANEL_2_ZF_Group_one_F1631209_028|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1631209_028|manual
	Live immune cells (CD45+ PE-)|2016-07-14_PANEL_2_ZF_Group_one_F1630932_010|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632064_023|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1631195_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-08_PANEL_2_ZF_Group_one_F1632338_006|manual
	CD14-|2016-07-08_PANEL_2_ZF_Group_one_F1632338_006|manual
	DC (HLA-DR+)|2016-07-11_PANEL_2_DHS_Group_one_F1632382_014|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632391_026|manual
	NK CD56LO|2016-07-14_PANEL_2_ZF_Group_one_F1632066_001|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-07-14_PANEL_2_ZF_Group_one_F1632066_001|manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-07-12_PANEL_2_DHS_Group_two_F1632107_030|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1630993_009|manual
	Live immune cells (CD45+ PE-)|2016-07-14_PANEL_2_ZF_Group_one_F1631230_004|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632386_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-08_PANEL_2_ZF_Group_two_F1632131_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-08_PANEL_2_ZF_Group_two_F1632284_028|manual
	CD14-|2016-07-12_PANEL_2_DHS_Group_two_F1631236_028|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1631271_008|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632122_031|manual
	Classical monocytes (CD16- CD14+)|2016-07-13_PANEL_2_ZF_Group_one_F1632122_031|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1631190_006|manual
	DC (HLA-DR+)|2016-07-11_PANEL_2_DHS_Group_one_F1632143_012|manual
	Classical monocytes (CD16- CD14+)|2016-07-11_PANEL_2_DHS_Group_one_F1632143_012|manual
	DC (HLA-DR+)|2016-07-11_PANEL_2_DHS_Group_one_F1632110_013|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1632409_007|manual
	NK CD56LO|2016-07-08_PANEL_2_ZF_Group_two_F1632363_025|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1631276_004|manual
	CD14-|2016-07-11_PANEL_2_DHS_Group_one_F1632344_009|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1632138_005|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-07_PANEL_2_ZF_Group_two_F1632076_032|manual
	NK CD56LO|2016-07-12_PANEL_2_DHS_Group_one_F1631201_006|manual
	CD14-|2016-07-11_PANEL_2_DHS_Group_two_F1632378_028|manual
	Classical monocytes (CD16- CD14+)|2016-07-11_PANEL_2_DHS_Group_two_F1632378_028|manual
	NK CD56LO|2016-07-11_PANEL_2_DHS_Group_one_F1632157_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-13_PANEL_2_ZF_Group_one_F1632154_029|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_one_F1632154_029|manual
	NK CD56LO|2016-07-13_PANEL_2_ZF_Group_two_F1632114_001|manual
	Live immune cells (CD45+ PE-)|2016-07-13_PANEL_2_ZF_Group_two_F1632114_001|manual
	DC (HLA-DR+)|2016-07-07_PANEL_2_ZF_Group_one_F1632381_007|manual
	NK CD56LO|2017-08-03_PANEL_2_LSR_ZF_Group_one_EC_F1638123_029|manual
	NK CD56LO|2017-08-04_PANEL_2_LSR_ZF_Group_two_ZF_F1635409_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-04_PANEL_2_FORTESSA_HB-postflowcelllubing_group_one_EC_F1642110_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-31_PANEL_2_LSR_ZF_Group_two_ZF_F1632623_018|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-31_PANEL_2_LSR_ZF_Group_one_ZF_F1632627_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-01_PANEL_2_FORTESSA_posttankreplacement_group_three_RR_F1641667_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-01_PANEL_2_FORTESSA_posttankreplacement_group_two_RR_F1639939_029|manual
	Classical monocytes (CD16- CD14+)|2017-08-04_PANEL_2_FORTESSA_HB-postflowcelllubing_group_two_ZF_F1642296_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-03_PANEL_2_LSR_ZF_Group_one_ZF_F1633227_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-31_PANEL_2_LSR_ZF_Group_one_ZF_F1637760_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-31_PANEL_2_LSR_ZF_Group_two_ZF_F1637074_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-01_PANEL_2_FORTESSA_posttankreplacement_group_three_RR_F1642055_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-31_PANEL_2_FORTESSA_ZF_group_one_ZF_F1637421_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-07-31_PANEL_2_LSR_ZF_Group_four_ZF_F1632645_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-03_PANEL_2_LSR_ZF_Group_one_EC_F1633270_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-04_PANEL_2_FORTESSA_HB-postflowcelllubing_group_two_ZF_F1642059_022|manual
	Classical monocytes (CD16- CD14+)|2017-08-04_PANEL_2_FORTESSA_HB-postflowcelllubing_group_two_ZF_F1642059_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-03_PANEL_2_LSR_ZF_Group_one_EC_F1642301_032|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-01_PANEL_2_FORTESSA_posttankreplacement_group_one_DHS_F1632506_001|manual
	NK CD56LO|2017-08-08_PANEL_2_LSR_DHS_Group_four_EC_F1639918_029|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-08_PANEL_2_LSR_DHS_Group_two_EC_Ctl-F_001|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-09_PANEL_2_LSR_ZF_Group_one_ZF_F1642062_002|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-09_PANEL_2_LSR_ZF_Group_three_RR_F1642431_037|Manual
	DC NK (CD20- CD14-)|2017-08-09_PANEL_2_LSR_ZF_Group_three_RR_F1632642_042|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-09_PANEL_2_LSR_ZF_Group_three_RR_F1632642_042|Manual
	NK CD56LO|2017-08-07_PANEL_2_LSR_DHS_Group_one_ZF_F1642043_038|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-07_PANEL_2_LSR_DHS_Group_one_DHS_F1633378_005|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-07_PANEL_2_LSR_DHS_Group_one_DHS_F1633378_005|Manual
	Classical monocytes (CD16- CD14+)|2017-08-08_PANEL_2_LSR_DHS_Group_one_DHS_F1632867_002|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-07_PANEL_2_FORTESSA_DHS_group_one_ZF_F1642307_033|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-07_PANEL_2_LSR_DHS_Group_one_EC_F1632511_027|Manual
	NK CD56LO|2017-08-07_PANEL_2_FORTESSA_DHS_group_two_EC_F1632888_032|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-07_PANEL_2_LSR_DHS_Group_one_DHS_F1632871_004|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-07_PANEL_2_LSR_DHS_Group_one_DHS_F1632871_004|Manual
	DC NK (CD20- CD14-)|2017-08-07_PANEL_2_FORTESSA_DHS_group_two_DHS_Ctl-E_022|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-09_PANEL_2_LSR_ZF_Group_two_ZF_F1642245_026|Manual
	Live immune cells (CD45+ PE-)|2017-08-10_PANEL_2_LSR_ZF_Group_five_EC_F1642215_035|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-07_PANEL_2_FORTESSA_DHS_group_one_EC_F1632491_024|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-09_PANEL_2_LSR_ZF_Group_three_RR_F1642295_033|Manual
	DC NK (CD20- CD14-)|2017-08-07_PANEL_2_FORTESSA_DHS_group_two_DHS_Ctl-E_001|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-07_PANEL_2_LSR_DHS_Group_one_EC_F1632755_026|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-07_PANEL_2_LSR_DHS_Group_one_DHS_F1642291_003|Manual
	NK CD56LO|2017-08-08_PANEL_2_FORTESSA_DHS_group_one_DHS_F1637644_002|Manual
	Classical monocytes (CD16- CD14+)|2017-08-07_PANEL_2_FORTESSA_DHS_group_one_EC_F1632550_023|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-08_PANEL_2_LSR_DHS_Group_two_DHS_F1642516_021|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-11_PANEL_2_FORTESSA_ZF_POSTALLIGNMENT_group_one_ZF_F1642452_001|manual
	NK CD56LO|2017-08-11_PANEL_2_LSR_ZF_Group_one_ZF_F1642143_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-15_PANEL_2_LSR_EC_Group_one_EC_F1642122_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_two_EC_F1634516_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_one_EC_F1642333_011|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_one_EC_F1637460_012|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-16_PANEL_2_LSR_EC_Group_one_EC_F1634764_009|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-16_PANEL_2_LSR_EC_Group_one_EC_F1634764_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-16_PANEL_2_LSR_EC_Group_three_RR_F1642287_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_two_EC_F1634784_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_one_EC_F1634735_007|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_three_ZF_F1634523_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-15_PANEL_2_LSR_EC_Group_two_EC_F1634736_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-11_PANEL_2_LSR_ZF_Group_two_ZF_F1642483_020|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_one_EC_Ctl-H_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_two_EC_F1634786_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-14_PANEL_2_LSR_EC_Group_one_EC_F1634779_010|manual
	Classical monocytes (CD16- CD14+)|2017-08-14_PANEL_2_LSR_EC_Group_one_EC_F1634779_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-11_PANEL_2_FORTESSA_ZF_POSTALLIGNMENT_group_four_ZF_F1642458_030|manual
	NK CD56LO|2017-08-15_PANEL_2_LSR_EC_Group_one_EC_F1634458_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-10_PANEL_2_LSR_ZF_Group_three_EC_F1642470_027|manual
	NK CD56LO|2017-08-18_PANEL_2_LSR_ZF_Group_one_ZF_F1642463_002|manual
	CD45+|2017-08-21_PANEL_2_LSR_DHS_Group_one_DHS_F1635355_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-18_PANEL_2_LSR_ZF_Group_two_ZF_F1633009_025|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-18_PANEL_2_LSR_ZF_Group_two_ZF_F1633009_025|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-21_PANEL_2_LSR_DHS_Group_two_DHS_F1642427_032|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-17_PANEL_2_LSR_EC_Group_two_EC_F1633064_032|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-17_PANEL_2_LSR_EC_Group_two_EC_F1634766_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-21_PANEL_2_LSR_DHS_Group_three_DHS_F1642448_043|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-22_PANEL_2_LSR_EC_Group_two_EC_Ctl-F_033|manual
	NK CD56LO|2017-08-23_PANEL_2_LSR_EC_Group_three_RR_F1633040_042|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-17_PANEL_2_LSR_EC_Group_two_EC_F1642283_025|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-23_PANEL_2_LSR_EC_Group_two_EC_F1642145_032|manual
	DC (HLA-DR+)|2017-08-22_PANEL_2_LSR_EC_Group_three_RR_F1642210_035|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-21_PANEL_2_LSR_DHS_Group_three_DHS_F1642310_040|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-21_PANEL_2_LSR_DHS_Group_three_DHS_F1642450_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-21_PANEL_2_LSR_DHS_Group_three_DHS_F1642524_042|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-21_PANEL_2_LSR_DHS_Group_two_DHS_F1642454_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-17_PANEL_2_LSR_EC_Group_one_EC_F1642253_010|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-17_PANEL_2_LSR_EC_Group_one_EC_F1642253_010|manual
	NK CD56LO|2017-08-18_PANEL_2_LSR_ZF_Group_two_ZF_F1641821_028|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-17_PANEL_2_LSR_EC_Group_two_EC_F1640509_027|manual
	NK CD56LO|2017-08-21_PANEL_2_LSR_DHS_Group_one_DHS_F1642203_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-18_PANEL_2_LSR_ZF_Group_three_HB_Ctl-F_043|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-22_PANEL_2_LSR_EC_Group_one_EC_F1642249_007|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-22_PANEL_2_LSR_EC_Group_two_EC_F1632564_030|manual
	DC (HLA-DR+)|2017-08-18_PANEL_2_LSR_ZF_Group_two_ZF_F1642211_026|manual
	DC (HLA-DR+)|2017-08-23_PANEL_2_LSR_EC_Group_one_EC_F1642167_010|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-22_PANEL_2_LSR_EC_Group_one_EC_F1642526_010|manual
	NK CD56LO|2017-08-21_PANEL_2_LSR_DHS_Group_three_DHS_F1639925_038|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-21_PANEL_2_LSR_DHS_Group_three_DHS_F1639925_038|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-17_PANEL_2_LSR_EC_Group_three_ZF_F1633251_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-21_PANEL_2_LSR_DHS_Group_two_DHS_F1642521_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-21_PANEL_2_LSR_DHS_Group_two_DHS_F1642422_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-21_PANEL_2_LSR_DHS_Group_two_DHS_F1642522_025|manual
	NK CD56LO|2017-08-21_PANEL_2_LSR_DHS_Group_two_DHS_F1642522_025|manual
	NK CD56LO|2017-08-23_PANEL_2_LSR_EC_Group_two_EC_F1642423_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-23_PANEL_2_LSR_EC_Group_one_EC_F1642185_001|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-17_PANEL_2_LSR_EC_Group_three_ZF_F1633259_040|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-18_PANEL_2_LSR_ZF_Group_three_HB_F1642188_039|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-17_PANEL_2_LSR_EC_Group_two_EC_F1642306_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-24_PANEL_2_LSR_EC_Group_one_EC_F1642221_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-25_PANEL_2_FORTESSA_HB_group_three_HB_F1634704_027|manual
	NK CD56LO|2017-08-24_PANEL_2_LSR_EC_Group_one_HB_F1642149_029|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-25_PANEL_2_FORTESSA_HB_group_one_HB_F1642402_005|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_three_HB_F1642364_027|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-25_PANEL_2_LSR_HB_Group_one_EC_F1642176_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-28_PANEL_2_FORTESSA_EC_group_two_ZF_F1634418_030|manual
	Classical monocytes (CD16- CD14+)|2017-08-29_PANEL_2_FORTESSA_EC_group_three_ZF_Ctl-E_036|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_three_HB_F1637435_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-25_PANEL_2_LSR_HB_Group_two_EC_F1634508_035|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-29_PANEL_2_FORTESSA_EC_group_one_EC_F1634510_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-25_PANEL_2_LSR_HB_Group_one_HB_F1642397_005|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_one_HB_F1642397_005|manual
	Classical monocytes (CD16- CD14+)|2017-08-28_PANEL_2_LSR_EC_Group_three_ZF_Ctl-E_039|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-25_PANEL_2_LSR_HB_Group_two_HB_F1642404_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-25_PANEL_2_LSR_HB_Group_one_HB_F1642392_004|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_two_HB_F1642363_020|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_two_HB_F1642335_019|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-08-25_PANEL_2_LSR_HB_Group_two_EC_F1634509_033|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_one_HB_F1642406_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-25_PANEL_2_LSR_HB_Group_two_HB_F1634732_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-28_PANEL_2_LSR_EC_Group_two_EC_F1634691_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-28_PANEL_2_FORTESSA_EC_group_two_EC_F1642399_021|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_two_EC_F1634669_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-29_PANEL_2_FORTESSA_EC_group_one_EC_F1642280_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-24_PANEL_2_LSR_EC_Group_one_HB_F1642164_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-29_PANEL_2_FORTESSA_EC_group_one_ZF_F1634622_023|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-25_PANEL_2_LSR_HB_Group_two_HB_F1637436_018|manual
	Classical monocytes (CD16- CD14+)|2017-08-25_PANEL_2_FORTESSA_HB_group_two_EC_Ctl-E_038|manual
	DC NK (CD20- CD14-)|2017-09-05_PANEL_2_LSR_EC_Group_one_RR_F1634638_027|Manual
	Classical monocytes (CD16- CD14+)|2017-08-30_PANEL_2_FORTESSA_ZF_group_one_RR_F1634643_025|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-09_27_PANEL_2_FORTESSA_EC_group_two_EC_F1631652_018|Manual
	Classical monocytes (CD16- CD14+)|2017-08-30_PANEL_2_FORTESSA_ZF_group_two_ZF_F1635094_018|Manual
	NK CD56LO|2017-09-05_PANEL_2_FORTESSA_EC_group_three_RR_F1634756_036|Manual
	Classical monocytes (CD16- CD14+)|2017-09-05_PANEL_2_FORTESSA_EC_group_one_EC_F1634569_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-29_PANEL_2_LSR_EC_Group_two_EC_F1634437_023|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-01_PANEL_2_LSR_ZF_Group_one_ZF_F1642367_004|Manual
	NK CD56LO|2017-09-01_PANEL_2_FORTESSA_ZF_group_one_RR_F1642237_023|Manual
	Classical monocytes (CD16- CD14+)|2017-09-01_PANEL_2_FORTESSA_ZF_group_one_RR_F1642237_023|Manual
	DC NK (CD20- CD14-)|2017-08-30_PANEL_2_LSR_ZF_Group_one_ZF_F1634632_001|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-30_PANEL_2_LSR_ZF_Group_one_ZF_F1634632_001|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-08-30_PANEL_2_LSR_ZF_Group_one_ZF_F1634426_004|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-08-30_PANEL_2_LSR_ZF_Group_one_ZF_F1634689_002|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-01_PANEL_2_LSR_ZF_Group_one_ZF_F1634869_002|Manual
	Classical monocytes (CD16- CD14+)|2017-08-30_PANEL_2_FORTESSA_ZF_group_one_ZF_F1634707_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09_27_PANEL_2_FORTESSA_EC_group_one_EC_Ctl-H_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-07_PANEL_2_FORTESSA_ZF_group_one_EC_F1634519_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_LSR_ZF_Group_three_EC_F1640071_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-07_PANEL_2_FORTESSA_ZF_group_two_EC_F1637773_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_LSR_ZF_Group_one_EC_F1642228_028|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-06_PANEL_2_FORTESSA_ZF_group_two_ZF_F1632880_019|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_LSR_ZF_Group_three_EC_F1640100_036|manual
	DC (HLA-DR+)|2017-09-07_PANEL_2_FORTESSA_ZF_group_two_EC_F1634792_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-07_PANEL_2_FORTESSA_ZF_group_one_EC_F1634597_024|manual
	Classical monocytes (CD16- CD14+)|2017-09-07_PANEL_2_FORTESSA_ZF_group_one_EC_F1634597_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-07_PANEL_2_LSR_ZF_Group_one_EC_F1634591_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-07_PANEL_2_LSR_ZF_Group_two_ZF_F1634824_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-07_PANEL_2_LSR_ZF_Group_one_ZF_F1642276_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_FORTESSA_ZF_group_two_ZF_Ctl-E_022|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_FORTESSA_ZF_group_one_ZF_F1640325_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_FORTESSA_ZF_group_two_EC_F1640085_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-07_PANEL_2_LSR_ZF_Group_two_ZF_F1634655_019|manual
	Classical monocytes (CD16- CD14+)|2017-09-07_PANEL_2_FORTESSA_ZF_group_one_EC_F1634789_027|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-06_PANEL_2_FORTESSA_ZF_group_two_EC_F1634833_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_FORTESSA_ZF_group_two_ZF_Ctl-E_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-11_PANEL_2_FORTESSA_ZF_group_two_EC_F1640081_029|manual
	Classical monocytes (CD16- CD14+)|2017-09-06_PANEL_2_FORTESSA_ZF_group_three_EC_F1634830_037|manual
	Classical monocytes (CD16- CD14+)|2017-09-13_PANEL_2_LSR_ZF_Group_one_ZF_F1640362_005|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-09-13_PANEL_2_LSR_ZF_Group_one_ZF_F1640362_005|manual
	Classical monocytes (CD16- CD14+)|2017-09-13_PANEL_2_FORTESSA_ZF_group_one_ZF_F1640146_004|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-13_PANEL_2_LSR_ZF_Group_two_EC_F1640145_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-13_PANEL_2_FORTESSA_ZF_group_two_EC_F1640348_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-14_PANEL_2_FORTESSA_EC_group_one_EC_F1634901_002|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-09-14_PANEL_2_LSR_ZF_Group_three_ZF_F1640105_033|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-09-11_PANEL_2_LSR_ZF_Group_two_ZF_F1642420_020|good
	Live Single PBMCs (SSC-A_FSC-A)|2017-09-13_PANEL_2_LSR_ZF_Group_one_ZF_F1638443_004|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-09-13_PANEL_2_LSR_ZF_Group_one_ZF_F1634574_003|manual
	DC (HLA-DR+)|2017-09-14_PANEL_2_LSR_ZF_Group_two_EC_F1631416_020|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-12_PANEL_2_FORTESSA_EC_group_one_RR_F1634606_025|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-09-11_PANEL_2_LSR_ZF_Group_two_ZF_F1634592_022|manual
	Classical monocytes (CD16- CD14+)|2017-09-13_PANEL_2_FORTESSA_ZF_group_one_ZF_F1634553_003|manual
	DC (HLA-DR+)|2017-09-14_PANEL_2_LSR_ZF_Group_two_ZF_F1642207_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-15_PANEL_2_FORTESSA_EC_group_one_EC_F1640149_004|manual
	Classical monocytes (CD16- CD14+)|2017-09-14_PANEL_2_FORTESSA_EC_group_two_ZF_F1631715_031|manual
	NK CD56LO|2017-09-12_PANEL_2_FORTESSA_EC_group_one_RR_F1640338_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-13_PANEL_2_LSR_ZF_Group_one_EC_F1640350_024|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-13_PANEL_2_LSR_ZF_Group_one_EC_F1631414_026|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-09-14_PANEL_2_LSR_ZF_Group_three_ZF_F1642227_036|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-12_PANEL_2_FORTESSA_EC_group_two_RR_F1642224_030|manual
	CD14-|2017-09-14_PANEL_2_FORTESSA_EC_group_three_ZF_F1640211_037|manual
	Classical monocytes (CD16- CD14+)|2017-09-14_PANEL_2_FORTESSA_EC_group_three_ZF_F1640211_037|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-12_PANEL_2_FORTESSA_EC_group_two_EC_F1632835_021|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-09-13_PANEL_2_LSR_ZF_Group_one_EC_F1640158_023|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-14_PANEL_2_LSR_ZF_Group_two_EC_F1634841_019|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-09-13_PANEL_2_LSR_ZF_Group_two_EC_F1640346_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-21_PANEL_2_LSR_EC_Group_one_EC_F1640115_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-21_PANEL_2_FORTESSA_EC_group_two_ZF_F1640388_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_FORTESSA_EC_group_three_ZF_F1640129_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_FORTESSA_EC_group_two_ZF_F1634854_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-21_PANEL_2_FORTESSA_EC_group_two_EC_F1634885_020|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_LSR_EC_Group_three_ZF_Ctl-H_038|manual
	Classical monocytes (CD16- CD14+)|2017-09-20_PANEL_2_LSR_EC_Group_three_ZF_Ctl-H_038|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-21_PANEL_2_FORTESSA_EC_group_one_ZF_F1639993_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_FORTESSA_EC_group_three_ZF_F1634849_034|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-15_PANEL_2_LSR_EC_Group_two_EC_F1634911_021|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-21_PANEL_2_LSR_EC_Group_one_EC_F1640385_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-15_PANEL_2_LSR_EC_Group_one_EC_F1634825_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_LSR_EC_Group_one_ZF_F1640126_026|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_LSR_EC_Group_three_ZF_F1640130_033|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_LSR_EC_Group_one_ZF_F1640118_023|manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-09-22_PANEL_2_FORTESSA_EC_group_two_RR_F1631480_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-20_PANEL_2_LSR_EC_Group_two_ZF_F1641488_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-15_PANEL_2_LSR_EC_Group_two_EC_F1631716_020|manual
	Classical monocytes (CD16- CD14+)|2017-10-02_PANEL_2_FORTESSA_EC_group_two_EC_F1638984_024|Manual
	CD14-|2017-09-25_PANEL_2_FORTESSA_EC_group_one_EC_F1631691_005|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-10-02_PANEL_2_FORTESSA_EC_group_one_EC_F1638914_008|Manual
	Classical monocytes (CD16- CD14+)|2017-09-28_PANEL_2_FORTESSA_EC_group_one_EC_F1638933_010|Manual
	Classical monocytes (CD16- CD14+)|2017-09-26_PANEL_2_LSR_RR_Group_two_RR_F1631425_019|Manual
	DC NK MONOCYTES (CD3- CD19-)|2017-09-26_PANEL_2_LSR_RR_Group_two_RR_F1631425_019|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-09-26_PANEL_2_LSR_RR_Group_one_RR_F1631427_004|Manual
	Classical monocytes (CD16- CD14+)|2017-09-25_PANEL_2_FORTESSA_EC_group_two_EC_F1640304_032|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-27_PANEL_2_LSR_EC_Group_one_ZF_F1631448_026|Manual
	Classical monocytes (CD16- CD14+)|2017-09-27_PANEL_2_LSR_EC_Group_one_ZF_F1631448_026|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-27_PANEL_2_LSR_EC_Group_one_ZF_F1634813_024|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-25_PANEL_2_FORTESSA_EC_group_two_EC_F1631418_026|Manual
	CD14-|2017-09-29_PANEL_2_FORTESSA_EC_group_two_EC_F1631700_027|Manual
	Classical monocytes (CD16- CD14+)|2017-09-27_PANEL_2_LSR_EC_Group_one_EC_F1640334_005|Manual
	Classical monocytes (CD16- CD14+)|2017-10-02_PANEL_2_FORTESSA_EC_group_two_EC_F1638936_027|Manual
	Classical monocytes (CD16- CD14+)|2017-10-03_PANEL_2_FORTESSA_EC_group_one_EC_F1631631_009|Manual
	NK CD56LO|2017-09-26_PANEL_2_FORTESSA_RR_group_one_RR_F1631447_001|Manual
	Classical monocytes (CD16- CD14+)|2017-10-02_PANEL_2_FORTESSA_EC_group_one_EC_F1631626_007|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-09-25_PANEL_2_FORTESSA_EC_group_one_EC_F1640136_003|Manual
	Classical monocytes (CD16- CD14+)|2017-10-02_PANEL_2_FORTESSA_EC_group_one_EC_F1634797_002|Manual
	Classical monocytes (CD16- CD14+)|2017-10-02_PANEL_2_FORTESSA_EC_group_one_EC_F1631617_006|Manual
	CD45+|2017-09-27_PANEL_2_LSR_EC_Group_two_EC_F1631683_019|Manual
	Classical monocytes (CD16- CD14+)|2017-09-27_PANEL_2_LSR_EC_Group_two_EC_F1631683_019|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2017-09-26_PANEL_2_LSR_RR_Group_two_RR_F1631471_020|Manual
	CD14-|2016-07-21_PANEL_2_ZF_Group_two_F1630936_031|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-20_PANEL_2_ZF_Group_two_F1631288_027|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-22_PANEL_2_ZF_Group_one_F1636514_008|Manual
	NK CD56LO|2016-07-22_PANEL_2_ZF_Group_one_F1636853_003|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-21_PANEL_2_ZF_Group_two_F1631000_029|Manual
	NK CD56LO|2016-07-18_PANEL_2_DHS_Group_one_F1631217_007|Manual
	Classical monocytes (CD16- CD14+)|2016-07-18_PANEL_2_DHS_Group_one_F1631217_007|Manual
	CD14-|2016-07-21_PANEL_2_ZF_Group_one_F1631232_008|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-18_PANEL_2_DHS_Group_one_F1631290_012|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-15_PANEL_2_ZF_Group_one_F1632389_010|Manual
	CD14-|2016-07-27_PANEL_2_ZF_Group_one_F1631305_002|Manual
	Classical monocytes (CD16- CD14+)|2016-07-27_PANEL_2_ZF_Group_one_F1631305_002|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-21_PANEL_2_ZF_Group_one_F1636522_004|Manual
	CD14-|2016-07-21_PANEL_2_ZF_Group_two_F1631216_032|Manual
	Classical monocytes (CD16- CD14+)|2016-07-18_PANEL_2_DHS_Group_two_F1636786_029|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-18_PANEL_2_DHS_Group_two_Ctl-D_031|Manual
	Classical monocytes (CD16- CD14+)|2016-07-18_PANEL_2_DHS_Group_two_Ctl-D_031|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-21_PANEL_2_ZF_Group_two_F1632282_025|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-20_PANEL_2_ZF_Group_two_F1631994_029|Manual
	NK CD56LO|2016-07-20_PANEL_2_ZF_Group_one_F1632388_003|Manual
	Live Single immune cells(FSC-H_FSC-W)|2017-10-04_PANEL_2_FORTESSA_ZF_group_two_ZF_F1631857_021|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_one_ZF_F1638977_001|manual
	Classical monocytes (CD16- CD14+)|2017-10-03_PANEL_2_FORTESSA_EC_group_one_EC_F1634751_008|manual
	Classical monocytes (CD16- CD14+)|2017-10-03_PANEL_2_FORTESSA_EC_group_one_EC_F1638985_007|manual
	Classical monocytes (CD16- CD14+)|2017-10-03_PANEL_2_FORTESSA_EC_group_one_EC_F1638975_010|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-05_PANEL_2_LSR_ZF_LOD_Group_one_Ctl-G_LOD_003_003|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-04_PANEL_2_LSR_ZF_Group_two_ZF_F1638969_018|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_one_ZF_F1631426_005|manual
	Classical monocytes (CD16- CD14+)|2017-10-03_PANEL_2_FORTESSA_EC_group_one_EC_F1638973_006|manual
	Classical monocytes (CD16- CD14+)|2017-10-03_PANEL_2_FORTESSA_EC_group_two_EC_F1631859_028|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_two_EC_F1631813_032|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_two_ZF_F1638978_019|manual
	Classical monocytes (CD16- CD14+)|2017-10-06_PANEL_2_FORTESSA_EC_group_one_EC_F1642177_003|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_one_EC_F1635572_025|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-06_PANEL_2_LSR_EC_Group_one_EC_F1631555_005|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-05_PANEL_2_LSR_ZF_LOD_Group_one_Ctl-G_LOD_008_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-10-16_PANEL_2_FORTESSA_ZF_group_one_ZF_F1631770_004|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-13_PANEL_2_LSR_EC_Group_two_EC_F1631568_022|manual
	Classical monocytes (CD16- CD14+)|2017-10-06_PANEL_2_FORTESSA_EC_group_two_EC_F1631583_020|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-04_PANEL_2_LSR_ZF_Group_two_EC_F1640381_029|manual
	Classical monocytes (CD16- CD14+)|2017-10-06_PANEL_2_FORTESSA_EC_group_one_RR_F1631543_027|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_one_EC_F1637541_026|manual
	CD14-|2017-10-16_PANEL_2_FORTESSA_ZF_group_one_HB_F1631748_026|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_one_EC_F1631826_028|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_two_ZF_F1631830_022|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-09_PANEL_2_LSR_ZF_Group_one_ZF_F1631569_002|manual
	CD14-|2017-10-06_PANEL_2_FORTESSA_EC_group_one_RR_F1631824_024|manual
	Classical monocytes (CD16- CD14+)|2017-10-06_PANEL_2_FORTESSA_EC_group_one_RR_F1631596_025|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-04_PANEL_2_LSR_ZF_Group_two_ZF_F1640291_019|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-10-12_PANEL_2_LSR_EC_Group_two_EC_F1631783_022|manual
	Classical monocytes (CD16- CD14+)|2017-10-06_PANEL_2_FORTESSA_EC_group_two_EC_F1631586_019|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_two_ZF_F1638971_020|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-05_PANEL_2_LSR_ZF_LOD_Group_one_Ctl-G_LOD_004_004|manual
	DC NK MONOCYTES (CD3- CD19-)|2017-10-16_PANEL_2_LSR_ZF_Group_one_ZF_F1631763_003|manual
	Classical monocytes (CD16- CD14+)|2017-10-04_PANEL_2_FORTESSA_ZF_group_one_ZF_F1631595_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-10-16_PANEL_2_FORTESSA_ZF_group_one_EC_F1631529_018|manual
	Live Single immune cells(FSC-H_FSC-W)|2017-10-12_PANEL_2_FORTESSA_EC_group_one_EC_Ctl-H_006|manual
	Classical monocytes (CD16- CD14+)|2017-10-12_PANEL_2_FORTESSA_EC_group_one_EC_Ctl-H_006|manual
	Classical monocytes (CD16- CD14+)|2017-10-06_PANEL_2_FORTESSA_EC_group_two_RR_F1631561_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-04_PANEL_2_ZF_Group_one_F1631094_004|manual
	NK CD56LO|2016-08-01_PANEL_2_DHS_Group_two_F1631147_030|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-04_PANEL_2_ZF_Group_two_F1632149_032|manual
	NK CD56LO|2016-08-03_PANEL_2_ZF_Group_two_F1631112_023|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-04_PANEL_2_ZF_Group_two_F1631079_024|manual
	DC (HLA-DR+)|2016-08-01_PANEL_2_DHS_Group_two_Ctl-A_032|manual
	CD45+|2016-07-29_PANEL_2_ZF_Group_one_F1636528_002|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-29_PANEL_2_ZF_Group_two_F1636859_027|manual
	Classical monocytes (CD16- CD14+)|2016-08-01_PANEL_2_DHS_Group_one_F1636819_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-05_PANEL_2_ZF_Group_one_F1631096_003|manual
	NK CD56LO|2016-08-01_PANEL_2_DHS_Group_one_F1636850_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-04_PANEL_2_ZF_Group_two_F1631071_027|manual
	NK CD56LO|2016-08-01_PANEL_2_DHS_Group_one_F1631377_002|manual
	NK CD56LO|2016-08-01_PANEL_2_DHS_Group_one_F1636533_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-27_PANEL_2_ZF_Group_two_Ctl-A_032|manual
	Classical monocytes (CD16- CD14+)|2016-08-02_PANEL_2_DHS_Group_two_F1631386_025|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-29_PANEL_2_ZF_Group_two_F1636856_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-29_PANEL_2_ZF_Group_one_F1636814_008|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-07-29_PANEL_2_ZF_Group_one_F1636814_008|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-05_PANEL_2_ZF_Group_one_F1631319_001|manual
	Classical monocytes (CD16- CD14+)|2016-08-01_PANEL_2_DHS_Group_two_F1636774_028|manual
	NK CD56LO|2016-08-03_PANEL_2_ZF_Group_two_F1631085_030|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-03_PANEL_2_ZF_Group_one_F1631379_009|manual
	NK CD56LO|2016-07-27_PANEL_2_ZF_Group_two_F1636521_023|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-04_PANEL_2_ZF_Group_one_F1631143_008|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-01_PANEL_2_DHS_Group_one_F1630927_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-07-27_PANEL_2_ZF_Group_two_F1636515_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-05_PANEL_2_ZF_Group_one_F1631197_006|manual
	DC (HLA-DR+)|2016-08-04_PANEL_2_ZF_Group_one_F1631063_010|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-05_PANEL_2_ZF_Group_one_F1636870_009|manual
	NK CD56LO|2016-08-17_PANEL_2_ZF_Group_one_F1631257_006|manual
	Classical monocytes (CD16- CD14+)|2016-08-17_PANEL_2_ZF_Group_one_F1631257_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-09_PANEL_2_DHS_Group_two_Ctl-A_032|manual
	CD14-|2016-08-16_PANEL_2_DHS_Group_one_F1632265_010|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-09_PANEL_2_DHS_Group_one_F1631097_003|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-09_PANEL_2_DHS_Group_one_F1631076_010|manual
	DC NK (CD20- CD14-)|2016-08-15_PANEL_2_DHS_Group_one_F1636844_011|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-15_PANEL_2_DHS_Group_one_F1636844_011|manual
	CD14-|2016-08-12_PANEL_2_ZF_Group_one_F1636854_006|manual
	NK CD56LO|2016-08-16_PANEL_2_DHS_Group_two_F1631249_031|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-15_PANEL_2_DHS_Group_two_Ctl-C_032|manual
	CD14-|2016-08-09_PANEL_2_DHS_Group_one_F1631090_012|manual
	CD14-|2016-08-09_PANEL_2_DHS_Group_one_F1631095_015|manual
	DC NK (CD20- CD14-)|2016-08-09_PANEL_2_DHS_Group_one_F1631380_005|manual
	CD45+|2016-08-15_PANEL_2_DHS_Group_one_F1631286_001|manual
	Live immune cells (CD45+ PE-)|2016-08-15_PANEL_2_DHS_Group_one_F1631286_001|manual
	CD45+|2016-08-12_PANEL_2_ZF_Group_two_F1631023_024|manual
	CD14-|2016-08-12_PANEL_2_ZF_Group_two_F1631023_024|manual
	Classical monocytes (CD16- CD14+)|2016-08-16_PANEL_2_DHS_Group_one_F1630981_009|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-16_PANEL_2_DHS_Group_one_F1630981_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-09_PANEL_2_DHS_Group_one_F1631323_007|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-16_PANEL_2_DHS_Group_two_F1636540_026|manual
	NK CD56LO|2016-08-12_PANEL_2_ZF_Group_one_F1630985_009|manual
	Classical monocytes (CD16- CD14+)|2016-08-12_PANEL_2_ZF_Group_one_F1630985_009|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-17_PANEL_2_ZF_Group_two_Ctl-A_032|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-12_PANEL_2_ZF_Group_one_F1636560_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-17_PANEL_2_ZF_Group_two_F1630975_024|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-11_PANEL_2_ZF_Group_one_F1631128_001|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-10_PANEL_2_ZF_Group_two_Ctl-B_010|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-10_PANEL_2_ZF_Group_two_Ctl-B_010|manual
	Live immune cells (CD45+ PE-)|2016-08-15_PANEL_2_DHS_Group_two_F1630983_031|manual
	DC NK (CD20- CD14-)|2016-08-11_PANEL_2_ZF_Group_one_F1636878_004|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-10_PANEL_2_ZF_Group_two_F1636876_005|manual
	CD14-|2016-08-16_PANEL_2_DHS_Group_one_F1632323_008|manual
	NK CD56LO|2016-08-16_PANEL_2_DHS_Group_one_F1631244_005|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-12_PANEL_2_ZF_Group_one_F1631385_005|manual
	Classical monocytes (CD16- CD14+)|2016-08-15_PANEL_2_DHS_Group_one_F1630924_010|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-12_PANEL_2_ZF_Group_two_F1630973_030|manual
	CD14-|2016-08-16_PANEL_2_DHS_Group_one_F1631247_002|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-12_PANEL_2_ZF_Group_two_F1631258_032|manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-12_PANEL_2_ZF_Group_two_F1631258_032|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-09_PANEL_2_DHS_Group_one_F1636763_006|manual
	DC (HLA-DR+)|2016-08-09_PANEL_2_DHS_Group_one_F1636763_006|manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-26_PANEL_2_HB-app_setting_reset_Group_one_Ctl-D_003|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-26_PANEL_2_HB-app_setting_reset_Group_one_Ctl-D_003|Manual
	NK CD56LO|2016-09-08_PANEL_2_ZF_Group_one_F1636896_003|Manual
	CD14-|2016-08-18_PANEL_2_ZF_Group_two_F1631250_032|Manual
	Classical monocytes (CD16- CD14+)|2016-08-18_PANEL_2_ZF_Group_two_F1631250_032|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-08-18_PANEL_2_ZF_Group_two_F1631250_032|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-08-31_PANEL_2_ZF_Group_one_F1636605_001|Manual
	CD14-|2016-08-29_PANEL_2_DHS_Group_one_F1631396_012|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-09-06_PANEL_2_DHS_Group_one_F1630938_003|Manual
	CD14-|2016-08-29_PANEL_2_DHS_Group_one_F1630974_008|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-29_PANEL_2_DHS_Group_two_F1630965_032|Manual
	CD14-|2016-08-29_PANEL_2_DHS_Group_one_F1636887_007|Manual
	CD14-|2016-08-29_PANEL_2_DHS_Group_one_F1631397_013|Manual
	CD14-|2016-08-29_PANEL_2_DHS_Group_one_F1631182_015|Manual
	CD14-|2016-08-18_PANEL_2_ZF_Group_one_F1632268_010|Manual
	Classical monocytes (CD16- CD14+)|2016-08-18_PANEL_2_ZF_Group_one_F1632268_010|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-08-18_PANEL_2_ZF_Group_one_F1632268_010|Manual
	CD14-|2016-08-19_PANEL_2_ZF_Group_one_F1631178_004|Manual
	Classical monocytes (CD16- CD14+)|2016-08-19_PANEL_2_ZF_Group_one_F1631178_004|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-08-19_PANEL_2_ZF_Group_one_F1631178_004|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-09-08_PANEL_2_ZF_Group_two_F1632152_029|Manual
	NK CD56LO|2016-08-30_PANEL_2_DHS_Group_one_F1631103_013|Manual
	CD14-|2016-08-30_PANEL_2_DHS_Group_one_F1631103_013|Manual
	Classical monocytes (CD16- CD14+)|2016-08-30_PANEL_2_DHS_Group_one_F1631103_013|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-08-30_PANEL_2_DHS_Group_one_F1631103_013|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-30_PANEL_2_DHS_Group_one_F1631103_013|Manual
	DC NK (CD20- CD14-)|2016-09-08_PANEL_2_ZF_Group_two_F1636587_028|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-09-08_PANEL_2_ZF_Group_two_F1636587_028|Manual
	NK CD56LO|2016-09-06_PANEL_2_DHS_Group_one_F1636590_015|Manual
	NK CD56LO|2016-09-06_PANEL_2_DHS_Group_one_F1636649_009|Manual
	NK CD56LO|2016-08-30_PANEL_2_DHS_Group_one_F1636538_011|Manual
	Classical monocytes (CD16- CD14+)|2016-08-30_PANEL_2_DHS_Group_one_F1636538_011|Manual
	Live immune cells (CD45+ PE-)|2016-08-30_PANEL_2_DHS_Group_one_F1630966_008|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-31_PANEL_2_ZF_Group_one_F1636601_010|Manual
	CD14-|2016-08-29_PANEL_2_DHS_Group_one_F1631179_001|Manual
	NK CD56LO|2016-09-06_PANEL_2_DHS_Group_one_F1631166_013|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-30_PANEL_2_DHS_Group_one_F1631009_006|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-26_PANEL_2_HB-app_setting_reset_Group_one_PBMC-A_001|Manual
	NK CD56LO|2016-08-26_PANEL_2_HB-app_setting_reset_Group_one_PBMC-A_001|Manual
	Classical monocytes (CD16- CD14+)|2016-08-18_PANEL_2_ZF_Group_two_F1631246_031|Manual
	Live Single PBMCs (SSC-A_FSC-A)|2016-08-18_PANEL_2_ZF_Group_two_F1631246_031|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-18_PANEL_2_ZF_Group_two_F1631246_031|Manual
	Live Single immune cells(FSC-H_FSC-W)|2016-08-19_PANEL_2_ZF_Group_one_F1631008_006|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-19_PANEL_2_ZF_Group_one_F1631008_006|Manual
	CD14-|2016-08-29_PANEL_2_DHS_Group_one_F1636874_016|Manual
	DC NK MONOCYTES (CD3- CD19-)|2016-08-17_PANEL_2_ZF_Group_two_F1636863_025|Manual
